Refluks żółciowy
Epidemiologia

Refluks żółciowy (bile reflux) to patologiczny wsteczny przepływ treści dwunastniczej, zawierającej żółć i wydzieliny trzustkowe, do żołądka (DGR) i potencjalnie do przełyku (DGER). Częstość występowania refluksu żółciowego jest zróżnicowana i wynosi od 7±8% u zdrowych osób do nawet 70% u pacjentów po operacjach bariatrycznych typu OAGB. Znacząco wyższe ryzyko refluksu obserwuje się po cholecystektomii (61,8%) oraz resekcji żołądka metodą Billroth II (60±24%). Refluks żółciowy jest istotnym czynnikiem patogenetycznym w chorobie refluksowej przełyku (GERD), szczególnie u pacjentów z ciężkim zapaleniem przełyku i przełykiem Barretta, gdzie częstość refluksu żółciowego sięga 70%. Wysoka obecność refluksu żółciowego u pacjentów opornych na inhibitory pompy protonowej (PPI) (do 68,7%) wskazuje na konieczność rozważenia tej etiologii w diagnostyce i leczeniu GERD. Refluks żółciowy przyczynia się do przewlekłego stanu zapalnego błony śluzowej, metaplazji jelitowej i zwiększa ryzyko rozwoju raka żołądka oraz przełyku.

Epidemiologia refluksu żółciowego

Refluks żółciowy (ang. bile reflux) jest zjawiskiem polegającym na wstecznym przepływie treści dwunastniczej zawierającej żółć, wydzieliny trzustkowe i jelitowe do żołądka (refluks dwunastniczo-żołądkowy, DGR) oraz potencjalnie do przełyku (refluks dwunastniczo-żołądkowo-przełykowy, DGER). Choć refluks żółciowy jest rzadki u zdrowych osób, jego występowanie i znaczenie kliniczne są szczególnie ważne w określonych populacjach pacjentów.123

Częstotliwość występowania refluksu żółciowego

Częstość występowania refluksu żółciowego różni się znacząco w zależności od badanej populacji. W badaniu obejmującym 804 przypadki, w których wykonano badanie endoskopowe z powodu bólu brzucha, refluks żółciowy zaobserwowano u 23,9% pacjentów.4 W innym badaniu częstość występowania żółciowego zapalenia błony śluzowej żołądka (BRG) wynosiła 16,7% w grupie kontrolnej (osoby bez interwencji w drogach żółciowych) oraz znacząco więcej – 61,8% w grupie po cholecystektomii.5 W koreańskim badaniu endoskopowy refluks żółciowy zidentyfikowano u 9,7% wszystkich przypadków z objawami żołądkowo-jelitowymi, przy czym najczęściej dotyczył młodych dorosłych (w wieku 30 lat) i był bardziej rozpowszechniony u kobiet.67

Częstość występowania refluksu dwunastniczo-żołądkowo-przełykowego (DGER) wśród wszystkich pacjentów z chorobą refluksową przełyku (GERD) waha się w szerokim zakresie od 10% do 97%, co wskazuje na znaczne różnice metodologiczne pomiędzy badaniami.8 Szczególnie wysoki odsetek pacjentów z GERD, którzy słabo reagują na leczenie inhibitorami pompy protonowej (PPI), ma refluks żółciowy, sięgający nawet 68,7%.910

Czynniki ryzyka refluksu żółciowego

Do głównych czynników ryzyka refluksu żółciowego należą:11121314

  • Zabiegi chirurgiczne żołądka i dróg żółciowych, w szczególności:
  • Dysfunkcja pęcherzyka żółciowego
  • Zaburzenia motoryki żołądka i dwunastnicy
  • Słaby lub szeroko otwarty odźwiernik
  • Cukrzyca typu 2 (z powodu osłabionej motoryki żołądka)
  • Przewlekłe stosowanie opioidów (osłabiających motorykę przewodu pokarmowego)

151617

Badania wieloczynnikowe wykazały, że dysfunkcja pęcherzyka żółciowego jest istotnym czynnikiem ryzyka refluksu żółciowego (OR 2,41; 95% CI, 0,62-9,31).18 Cholecystektomia znacząco zwiększa ryzyko refluksu żółciowego (OR 6,60; 95% CI, 1,87-23,30; P = 0,003).19

Refluks żółciowy po zabiegach chirurgicznych

Refluks żółciowy jest najczęściej rozpoznawany jako powikłanie zabiegów chirurgicznych, szczególnie operacji żołądka, które omijają, uszkadzają lub zastępują zastawkę odźwiernikową.20 Badania z wykorzystaniem 24-godzinnego monitorowania stężenia bilirubiny w żołądku wykazały, że refluks dwunastniczo-żołądkowy był najwyższy po resekcji żołądka metodą Billroth II (60±24%). Pacjenci po cholecystektomii (28±25%), pacjenci z chorobą refluksową przełyku (24±24%) oraz pacjenci z dyspepsją czynnościową (23±21%) mieli znacznie wyższy poziom refluksu dwunastniczo-żołądkowego niż zdrowe osoby (7±8%, P≤0,0001).21

W kontekście chirurgii bariatrycznej, częstość występowania refluksu żółciowego po operacjach bariatrycznych była heterogenicznie raportowana w wielu badaniach. Lasheen i wsp. ocenili częstość występowania żółciowego zapalenia błony śluzowej żołądka i przełyku u ponad 40 pacjentów po MGB (Mini Gastric Bypass) i stwierdzili, że 20% z nich miało refluks żółciowy zdiagnozowany na podstawie biopsji żołądka i badania aspiratu żołądkowego.22 Raportowana częstość występowania refluksu żółciowego była wyższa po MGB w porównaniu do innych operacji bariatrycznych.23

W niedawnym badaniu oceniającym refluks żółciowy po operacjach bariatrycznych, refluks żółciowy do żołądka zidentyfikowano za pomocą scyntygrafii u 70% pacjentów po OAGB (One Anastomosis Gastric Bypass), 5% po RYGB (Roux-en-Y Gastric Bypass) i 31% po SG (Sleeve Gastrectomy). Jednak refluks żółciowy do przełyku zaobserwowano tylko u jednego uczestnika po OAGB.24 Z kolei po operacji SADI-S (Single-Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy) zgłaszana częstość występowania refluksu żółciowego jest niska i wynosi około 0,1%.25

Refluks żółciowy w chorobie refluksowej przełyku

Refluks żółciowy odgrywa istotną rolę w patogenezie i ciężkości choroby refluksowej przełyku (GERD). Choroba ta jest powszechna na całym świecie, a jej częstość występowania waha się od 10% do 20% w populacjach zachodnich do 2,5-17,0% w populacjach azjatyckich.2627 Zakres szacunków częstości występowania GERD wynosi 18,1-27,8% w Ameryce Północnej, 8,8-25,9% w Europie, 2,5-7,8% we Wschodniej Azji, 8,7-33,1% na Bliskim Wschodzie, 11,6% w Australii i 23,0% w Ameryce Południowej.28

Częstotliwość refluksu żółciowego w GERD

Refluks żółciowy jest szczególnie częsty u pacjentów z chorobą refluksową przełyku, zwłaszcza u tych z ciężkim zapaleniem przełyku i/lub przełykiem Barretta.29 Istnieje wyraźna korelacja między ilością refluksu żółciowego a nasileniem zapalenia dystalnej części przełyku. Pacjenci z najcięższym stopniem zapalenia żołądkowo-przełykowego, przełykiem Barretta, mają największą ilość refluksu żółciowego.30

Badania wykazały, że wysoki odsetek (53,3%) pacjentów z GERD bez zapalenia przełyku ma patologiczny refluks żółciowy, wzrastający do 70% u pacjentów z zapaleniem przełyku.31 Badanie przeprowadzone przez Dixon i wsp. wykazało, że pacjenci z przełykiem Barretta mieli więcej dowodów na zapalenie żołądka związane z żółcią w porównaniu z pacjentami, u których zdiagnozowano tylko GERD lub dyspepsję bez owrzodzenia.32

Obserwacje te sugerują, że wysoki odsetek pacjentów słabo reagujących na terapię PPI może wynikać ze słabej kontroli refluksu dwunastniczo-żołądkowo-przełykowego (DGER).3334 Wiele badań wskazuje, że u wielu pacjentów bez zapalenia przełyku występuje jednoczesny refluks kwasu i żółci, który nasila się wraz z narastaniem stopnia zapalenia przełyku.35

Związek refluksu żółciowego z opornym GERD

Do 50% pacjentów z chorobą refluksową przełyku (GERD) nie reaguje objawowo, częściowo lub całkowicie, na inhibitory pompy protonowej (PPI).36 Większość pacjentów z GERD, którzy nie reagują na PPI, ma albo nieerozyjną chorobę refluksową (NERD), albo czynnościową zgagę. U pacjentów z NERD zbiorczy wskaźnik odpowiedzi objawowej na PPI raz dziennie po czterech tygodniach wynosi 37%. W przeciwieństwie do tego, u pacjentów z zapaleniem nadżerkowym przełyku, które stanowi 30-40% populacji GERD, zbiorczy wskaźnik odpowiedzi objawowej wynosi 56%.37

Ponieważ kwasy żółciowe są często obecne w refluksie żołądkowo-przełykowym, mogą powodować zmiany zapalne i nowotworowe w górnym odcinku przewodu pokarmowego.38 Jest to szczególnie istotne, ponieważ inhibitory pompy protonowej nie zmniejszają obecności kwasów żółciowych w refluksacie (ponieważ PPI nie redukują obecności kwasów żółciowych). Kwasy żółciowe mogą mieć wpływ na błonę śluzową przełyku u pacjentów z nieerozyjną chorobą refluksową i mogą być związane z utrzymywaniem się objawów u tych pacjentów.39

Refluks żółciowy a ryzyko nowotworowe

Coraz więcej badań wykazuje, że refluks żółciowy jest ściśle związany z rozwojem zmian przedrakowych i rakiem żołądka (GC) i może być niezależnym czynnikiem ryzyka GC.40 Wieloośrodkowe, przekrojowe i obserwacyjne badanie przeprowadzone w pięciu ośrodkach w Chinach wykazało, że niezależnymi czynnikami ryzyka nowotworowych zmian żołądka były stopień refluksu żółciowego, wiek pacjenta, nawyki żywieniowe i historia rodzinna raka żołądka.41

Refluks żółciowy a przełyk Barretta

Refluks żółciowy lub dwunastniczo-żołądkowy jest proponowany w etiologii przełyku Barretta (BE), ponieważ kwasy żółciowe zostały znalezione w refluksacie pacjentów z BE. Sugeruje się, że kwasy żółciowe mogą wywierać swoje działanie na błonę śluzową przełyku poprzez szlaki cytotoksyczne i regulację w górę proto-onkogenu i c-myc, powodując stan zapalny i przyczyniając się do kaskady zapalenie-rak.42

Endoskopowe dowody refluksu żółciowego są związane z obecnością przełyku Barretta (BE) (OR, 5,65; 95% CI, 4,71-6,76; P <.001), co sugeruje, że to endoskopowe znalezisko może pomóc zidentyfikować pacjentów zagrożonych rozwojem BE i którzy mogliby skorzystać z nadzoru endoskopowego.43

Kwasy żółciowe stają się niejonizowane przy kwaśnym pH, wnikają do komórek i wywołują uszkodzenie błony śluzowej i stan zapalny. Wpływ kwasu żółciowego okazał się najsilniejszy w połączeniu z kwasem żołądkowym.44 Pacjenci z bardziej zaawansowanymi zmianami przełykowymi mają wyższy stopień refluksu dwunastniczego. W modelach zwierzęcych i in vitro wykazano więcej przełyku Barretta i dysplazji przy refluksie dwunastniczym.45

Refluks żółciowy a nowotwory górnego odcinka przewodu pokarmowego

Długotrwała ekspozycja na kwasy żółciowe zwiększa ryzyko przejścia od normalnej błony śluzowej do metaplazji jelitowej, co ostatecznie prowadzi do rozwoju raka żołądka w ciągu wielu lat.46 Mimo że znane są histopatologiczne powiązania między ekspozycją błony śluzowej przełyku na żółć a karcinogenezą, tylko dwa przypadki złośliwości uchyłka żołądkowego/dystalnego przełyku zostały opisane w ciągu 20 lat od pojawienia się OAGB.47

Refluks żółciowy wydaje się być czynnikiem przyczynowym w ludzkim raku płaskonabłonkowym gardła dolnego.48 Najnowsze dane in vitro i in vivo dostarczają dowodów na karcinogenezę gardła dolnego związaną z refluksem żółciowym.49 Badania na modelach zwierzęcych wykazały, że sam refluks żółciowy powoduje raka przełyku.50

Żółciowe zapalenie błony śluzowej żołądka jest uważane za czynnik ryzyka raka żołądka, ale nie jest poważnie traktowane w oddziałach gastroenterologicznych.51 Coraz więcej dowodów wykazało, że przewlekły stan zapalny błony śluzowej żołądka spowodowany refluksem żółciowym jest kluczowym czynnikiem patogennym metaplazji jelitowej żołądka.52

Zmiany w trendach epidemiologicznych refluksu żółciowego

W ostatnich dekadach obserwuje się zmiany w epidemiologii refluksu żółciowego oraz powiązanej z nim choroby refluksowej przełyku. Dane wskazują na wzrost częstości występowania GERD od 1995 roku (p<0,0001), szczególnie w Ameryce Północnej i Wschodniej Azji.53

Wzrost częstości refluksu w populacji ogólnej

Globalna standaryzowana względem wieku częstość występowania GERD pozostała stosunkowo stabilna, z szacunkową wartością 9574,45 na 100 000 populacji w 2019 roku.54 Korzystając z ONZ-owskiej Prognozy Ludności Świata 2017, szacunkowa liczba osób cierpiących na GERD na całym świecie wynosi 1,03 miliarda.55 Ten kompleksowy przegląd systematyczny wykazał znaczne obciążenie globalne GERD, co wiąże się również z potencjalnym wzrostem częstości występowania refluksu żółciowego.56

Przegląd systematyczny badań podłużnych sugeruje, że zapadalność na GERD wzrosła w ostatnich dziesięcioleciach. Jeśli ten trend się utrzyma, może szybko zwiększyć poważne powikłania GERD, wpłynąć na jakość życia pacjentów i zwiększyć koszty systemów opieki zdrowotnej.57

Refluks żółciowy w młodszej populacji

W ciągu ostatniej dekady nastąpił znaczący wzrost odsetka młodszych pacjentów z GERD, szczególnie tych w przedziale wiekowym 30-39 lat.58 Wzrost częstości występowania GERD może być spowodowany wieloma czynnikami, takimi jak starszy wiek, płeć męska, rasa, przyjmowanie leków przeciwbólowych, spożywanie określonych rodzajów żywności i napojów, zmniejszenie częstości występowania zakażenia Helicobacter pylori, palenie tytoniu, historia rodzinna GERD, wysoki wskaźnik masy ciała (BMI) i ograniczona aktywność fizyczna.59

Badanie endoskopowego refluksu żółciowego wykazało, że jest to częste zjawisko u młodych dorosłych (w wieku 30 lat) w poradniach ambulatoryjnych.6061 Sugeruje to, że lekarze powinni być bardziej świadomi, że odsetek młodych dorosłych z GERD stale rośnie, co może również przekładać się na wzrost częstości refluksu żółciowego w tej populacji.62

Monitorowanie i wykrywanie refluksu żółciowego

Diagnoza refluksu żółciowego jest nadal trudna ze względu na nietypowe objawy kliniczne i niespecyficzne badania pomocnicze.63 Chociaż nie ma złotego standardu do diagnozy żółciowego zapalenia błony śluzowej żołądka (BRG), cztery kluczowe techniki są powszechnie uznawane:64

65

Scyntygrafia HIDA jest najmniej inwazyjnym badaniem z dobrą tolerancją przez pacjentów, czułością i powtarzalnością w diagnostyce refluksu żółciowego.66 Badanie HIDA jest czułą miarą patologii kikuta i jest łatwo dostępnym nieinwazyjnym testem.67

Badania z wykorzystaniem rezonansu magnetycznego z kontrastem specyficznym dla hepatocytów (MRC z kwasem gadoksetowym) wykazały również korelację między wydzielanym do dróg żółciowych środkiem kontrastowym w żołądku a obecnością żółciowego zapalenia błony śluzowej żołądka. Żółciowe zapalenie błony śluzowej żołądka było znacznie częstsze u pacjentów ze środkiem kontrastowym w żołądku w gadoksetycznym MRC (13/39 [33,3%]) niż u tych bez środka kontrastowego (0/72 [0%]; P≤0,001).68

Wyniki badania liniowo-liniowego wykazały, że pacjenci z wysokim stopniem rozszerzenia środka kontrastowego w żołądku mieli znacznie częstsze żółciowe zapalenie błony śluzowej żołądka niż pacjenci z niskim stopniem rozszerzenia. Sugeruje to, że czułość MRI ze wzmocnieniem kwasem gadoksetowym jest lepsza niż gastroskopia w diagnostyce żółciowego zapalenia błony śluzowej żołądka.6970

W ambulatoryjnym monitorowaniu refluksu żółciowego (Bilitec), aby uniknąć artefaktów z powodu zaklinowania pokarmu, niektóre grupy pozwalały tylko na dietę płynną, podczas gdy inne pomijały okresy posiłków i poposiłkowe z analizy. Ambulatoryjne monitorowanie Bilitec wymaga stosowania płynnych posiłków, ponieważ stosowanie posiłków stałych wiąże się ze zbyt wieloma artefaktami posiłkowymi i gorszą korelacją z refluksem kwasowym i ciężkością zmian endoskopowych.71

Wpływ refluksu żółciowego na zdrowie publiczne

Refluks żółciowy, jako składnik choroby refluksowej przełyku lub jako niezależna jednostka chorobowa, ma znaczący wpływ na zdrowie publiczne. Związane z nim choroby, takie jak GERD, dotyczą znacznej części populacji światowej.72

Obciążenie systemów opieki zdrowotnej

Choroba refluksowa przełyku jest powszechną chorobą na całym świecie, z rosnącą częstością występowania i w konsekwencji większym obciążeniem systemu opieki zdrowotnej.73 Ponieważ refluks żółciowy często współistnieje z GERD lub jest mylnie diagnozowany jako GERD, przyczynia się do tego obciążenia.74

W Stanach Zjednoczonych 20% osób ma objawy w danym tygodniu, a 7% codziennie, co wskazuje na znaczne rozpowszechnienie problemów związanych z refluksem.75 Na całym świecie różnice w częstości występowania GERD pokazują, że tylko wschodnia Azja konsekwentnie wykazuje szacunki poniżej 10%, co sugeruje, że większość światowej populacji ma znaczące ryzyko problemów związanych z refluksem, w tym refluksem żółciowym.76

Zwiększanie świadomości na temat GERD w celu poprawy zdrowia ludzkiego może być konieczne. Istnieje wiele informacji w kulturach zachodnich, które można uogólnić na osobę irańską, ale nie mogą całkowicie pasować. Dlatego zrozumienie epidemiologicznych skutków GERD w społeczeństwie irańskim może pomóc pracownikom służby zdrowia i decydentom podjąć kolejne kroki w tworzeniu listy priorytetów zarządzania chorobami.77 Podobne podejście może być korzystne w innych regionach o wysokiej częstości występowania refluksu żółciowego.

Refluks żółciowy w różnych grupach demograficznych

Istnieją znaczne różnice w częstości występowania refluksu żółciowego i GERD w różnych grupach demograficznych. Częstość występowania GERD według grup wiekowych wykazuje wzrost wraz z wiekiem między grupami wiekowymi 18-34 lat (8,70%) i 35-59 lat (14,53%).78 Istnieje również umiarkowana różnica między płciami, z łączną częstością występowania GERD u kobiet (17,17%) nieznacznie wyższą niż u mężczyzn (15,69%).79

Niektóre badania wskazują, że mężczyźni są bardziej narażeni na rozwój ciężkich form zapalenia przełyku i powikłań, takich jak przełyk Barretta i gruczolakorak przełyku. Natomiast kobiety częściej cierpią na nieerozyjną chorobę refluksową (NERD) i objawowy GERD.8081

Interesujące jest, że badanie z Tajwanu autorstwa Chen i wsp. wykazało sezonowe wahania w częstości występowania GERD. Badacze ocenili łącznie 76 636 ambulatoryjnych wizyt w celu leczenia GERD w latach 2001-2006 i raportowali, że częstość występowania GERD wzrosła jesienią i zimą dla każdej płci, grupy wiekowej, a także grup łączonych.82

Częstość występowania refluksu żółciowego w różnych populacjach
Populacja Częstość występowania Źródło badania
Osoby bez interwencji w drogach żółciowych 16,7% Badanie częstości BRG
Pacjenci po cholecystektomii 61,8% Badanie częstości BRG
Pacjenci z objawami żołądkowo-jelitowymi (endoskopowy refluks żółciowy) 9,7% Badanie koreańskie
Pacjenci z GERD opornym na PPI 68,7% Badanie oporności na PPI
GERD bez zapalenia przełyku z refluksem żółciowym 53,3% Badanie pacjentów z GERD
GERD z zapaleniem przełyku z refluksem żółciowym 70% Badanie pacjentów z GERD
Refleks żółciowy po resekcji Billroth II 60±24% 24-godzinne monitorowanie bilirubiny
Refluks żółciowy po OAGB (do żołądka) 70% Badanie scyntygraficzne
Refluks żółciowy po RYGB (do żołądka) 5% Badanie scyntygraficzne
Refluks żółciowy po SG (do żołądka) 31% Badanie scyntygraficzne
Refluks żółciowy po SADI-S 0,1% Raportowana częstość
Zdrowe osoby 7±8% 24-godzinne monitorowanie bilirubiny

Czynniki społeczno-ekonomiczne wpływające na refluks żółciowy

Częstość występowania GERD, a tym samym potencjalnie refluksu żółciowego, jest związana z różnymi czynnikami społeczno-ekonomicznymi. Stratyfikowana łączna częstość występowania GERD według BMI wykazała wzrost częstości występowania GERD wraz ze wzrostem BMI.83

Najwyższą częstość występowania GERD stwierdzono u osób rozwiedzionych/w separacji/owdowiałych (22,95%), następnie u osób w związku małżeńskim (15,98%), a najniższą częstość występowania GERD stwierdzono u osób stanu wolnego (12,85%).84

Częstość występowania GERD była najwyższa u osób z niskim poziomem wykształcenia (16,78%), następnie u osób ze średnim poziomem wykształcenia (11,52%), a najniższa częstość występowania GERD była obserwowana u osób z wysokim poziomem wykształcenia (8,98%).85

Osoby o niskich dochodach miały znacznie wyższą częstość występowania GERD (11,69%) niż osoby o średnich dochodach (8,42%) i osoby o wysokich dochodach (7,68%).86

Miejsce zamieszkania również miało znaczący wpływ na częstość występowania GERD. Łączna częstość występowania GERD u osób mieszkających na obszarach miejskich była najwyższa (13,43%), następnie u osób mieszkających na obszarach wiejskich (11,70%).87

Wpływ stylu życia na refluks żółciowy

Różne czynniki stylu życia mają wpływ na częstość występowania GERD i potencjalnie refluksu żółciowego. Osoby, które obecnie palą, miały wyższą częstość występowania GERD (18,40%) w porównaniu z byłymi palaczami (16,83%) i osobami niepalącymi (15,55%).88

Łączna częstość występowania GERD według spożycia alkoholu wykazała podobną częstość występowania GERD u osób, które nie piją alkoholu lub mają niskie spożycie alkoholu (15,95%) w porównaniu z osobami, które mają umiarkowane do wysokiego spożycie alkoholu (15,56%).89

Badano również wpływ spożycia określonych pokarmów i napojów na łączną częstość występowania GERD. Osoby z umiarkowanym/wysokim spożyciem napojów gazowanych miały wyższą łączną częstość występowania GERD niż osoby z niskim/żadnym spożyciem (18,60% vs 14,54%).90

Łączna częstość występowania GERD według spożycia kawy/herbaty ujawniła wyższą częstość występowania GERD u osób z umiarkowanym/wysokim spożyciem kawy/herbaty (21,02%) niż u osób z niskim/żadnym spożyciem (16,92%).91

Nadzór epidemiologiczny refluksu żółciowego

Nadzór epidemiologiczny nad refluksem żółciowym jest istotnym elementem zarządzania zdrowiem publicznym, jednak stanowi wyzwanie ze względu na trudności diagnostyczne i różnorodność metodologii badawczych.9293

Wyzwania w prowadzeniu nadzoru

Istnieje niewiele dowodów oceniających skuteczność leczenia refluksu żółciowego, częściowo ze względu na trudności w ustaleniu refluksu żółciowego jako przyczyny objawów.94 Trudność w radiograficznej diagnozie choroby refluksowej przełyku leży w obecności spontanicznego refluksu w badaniu górnego odcinka przewodu pokarmowego u 20% zdrowych osób, podczas gdy niektórzy pacjenci z patologiczną chorobą refluksową przełyku mogą prezentować refluks tylko po manewrach prowokacyjnych, takich jak manewr Valsalvy, podnoszenie nóg i kaszel.95

Opisanie objawów i znajomość historii medycznej zwykle wystarczają lekarzowi do zdiagnozowania problemu refluksowego. Ale rozróżnienie między refluksem kwasowym a refluksem żółciowym jest trudne i wymaga dalszych badań.96 Ponieważ objawy refluksu kwasowego i refluksu żółciowego są tak podobne, niemożliwe jest postawienie diagnozy refluksu żółciowego wyłącznie na podstawie objawów.97

Nie ma złotego standardu badania dla refluksu żółciowego przełykowego, a w kilku badaniach oceniających go po operacji otyłości stosowano różne metody. Jako takie, dane dotyczące częstości występowania i nasilenia refluksu żółciowego przełyku są ograniczone, a badania porównawcze są niewystarczające.98

Znaczenie rozszerzenia nadzoru epidemiologicznego

Badania sugerują potrzebę rozszerzenia nadzoru epidemiologicznego nad refluksem żółciowym, szczególnie w przypadku pacjentów poddanych określonym zabiegom chirurgicznym lub z podwyższonym ryzykiem powikłań. Na przykład, wyniki sugerują, że prospektywne badania OAGB powinny obejmować endoskopię przed operacją i w 5-letnich odstępach, aby dostarczyć danych na temat rzeczywistych skutków ekspozycji na żółć w zbiorniku żołądkowym i przełyku.99100

Identyfikacja refluksu żółciowego jest ważna, ponieważ pacjenci doświadczający go mogą mieć poważniejsze uszkodzenia błony śluzowej przełyku, w tym przełyk Barretta.101 Dlatego pacjenci z dowodami refluksu żółciowego powinni być rozważani do bardziej agresywnej terapii, w nadziei na potencjalne zapobieganie negatywnym następstwom, takim jak przełyk Barretta.102

Obecnie jednak nie ma jasnych badań na temat tego, czy monitorowanie refluksu żółciowego może być wykorzystane do monitorowania i opóźniania rozwoju metaplazji jelitowej żołądka.103 Istnieje również kontrowersyjna debata na temat tego, czy metaplazja jelitowa żołądka jest odwracalna i czy leczenie refluksu żółciowego może ją odwrócić.104

W związku z rosnącą epidemią otyłości i zwiększeniem liczby operacji utraty wagi nastąpiło odrodzenie zainteresowania refluksem żółciowym, ponieważ zmiany anatomiczne mogą być refluksogenne. Prospektywne badania nad procedurami OAGB powinny obejmować endoskopię przed operacją i w 5-letnich odstępach, aby dostarczyć danych na temat rzeczywistych skutków ekspozycji na żółć w zbiorniku żołądkowym i przełyku.105

Pacjenci, którzy mają refluks żółciowy po operacji bariatrycznej SADI-S, stanowią rzadkość, ale ważne jest monitorowanie, ponieważ refluks żółciowy może pojawić się od kilku miesięcy do kilku lat po SADI-S i powinien być leczony chirurgicznie, jeśli wystąpi.106

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 09.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Bile Reflux: Symptoms, Treatment, Causes & What It Is
    https://my.clevelandclinic.org/health/diseases/22056-bile-reflux
    Bile reflux is not thought to be common in otherwise healthy individuals. […] Bile reflux is most commonly recognized as a complication of surgery, particularly stomach surgery that bypasses, damages or replaces the pyloric valve. […] Bile (or non-acid) reflux is not common, but its a known complication of certain surgeries.
  • #2 Biliary reflux – Wikipedia
    https://en.wikipedia.org/wiki/Biliary_reflux
    Bile reflux is very infrequent in healthy individuals. […] Bile acids are frequently present in the gastroesophageal refluxate, and thus can cause inflammatory and neoplastic changes in the upper aerodigestive tract. […] Bile reflux appears to be a causal factor in human hypopharyngeal squamous cell carcinoma.
  • #3 Bile reflux: Symptoms, causes, treatment and more
    https://www.medicalnewstoday.com/articles/bile-reflux
    Bile reflux tends to be uncommon in people who do not have any health problems, but it is a well-known complication of certain surgeries. […] Bile reflux can happen for the following reasons: as a complication of surgery, such as bariatric or gallbladder surgery. […] Bile reflux usually requires medications and, sometimes, surgery. If left untreated, bile reflux can irritate the GI tract and increase the risk of complications.
  • #4 Bile Reflux Gastritis: Insights into Pathogenesis, Relevant Factors, Carcinomatous Risk, Diagnosis, and Management
    https://pmc.ncbi.nlm.nih.gov/articles/PMC9484982/
    Bile reflux gastritis (BRG), a kind of gastrointestinal disorder in clinical practice, is characterized by regurgitation and inflammation. However, lack of guidelines leads to simple cognition and even ignorance of this disease for clinicians. Primarily, making the pathogenesis of BRG clear contributes to a correct and general understanding of this disease for physicians. […] In terms of its prevalence, a study including 804 cases where there was an endoscopic examination for abdominal pain found bile reflux was seen in 23.9% patients. Another research observed that the prevalence of BRG was 16.7% and 61.8% in the control group, who had never undergone any biliary interventions and the postcholecystectomy group who had undergone cholecystectomy. […] The prevalence of DGER among all GERD patients ranged from 10% to 97%.
  • #5 Bile Reflux Gastritis: Insights into Pathogenesis, Relevant Factors, Carcinomatous Risk, Diagnosis, and Management
    https://pmc.ncbi.nlm.nih.gov/articles/PMC9484982/
    Bile reflux gastritis (BRG), a kind of gastrointestinal disorder in clinical practice, is characterized by regurgitation and inflammation. However, lack of guidelines leads to simple cognition and even ignorance of this disease for clinicians. Primarily, making the pathogenesis of BRG clear contributes to a correct and general understanding of this disease for physicians. […] In terms of its prevalence, a study including 804 cases where there was an endoscopic examination for abdominal pain found bile reflux was seen in 23.9% patients. Another research observed that the prevalence of BRG was 16.7% and 61.8% in the control group, who had never undergone any biliary interventions and the postcholecystectomy group who had undergone cholecystectomy. […] The prevalence of DGER among all GERD patients ranged from 10% to 97%.
  • #6 KoreaMed Synapse
    https://synapse.koreamed.org/articles/1058566
    Endoscopic bile reflux identified in 9.7% of all cases with gastrointestinal symptoms. […] Endoscopic bile reflux was common findings with young adults (30’s) at outpatients clinic. […] Bile reflux also had distinguishable ultra-structural changes identifiable by EM. […] GB dysfunction were identified as significant risk factors for BRI (+) group. […] The BRI (+) group had more old age, GB dysfunction than BRI (-) group. […] The BRI (+) group correlated with GB dysfunction (OR, 2.41; 95% CI, 0.62 to 9.31). […] Endoscopic bile reflux (9.7%) is a very common disease encountered in the outpatients clinic. It was found to be common in young adults (30’s) and more predominant in females. […] Bile reflux inhibited colonization of H. pylori in the stomach. […] BRI (+) group had more old age and GB dysfunction than BRI (-) group.
  • #7 Cited
    https://www.koreamed.org/SearchBasic.php?RID=2284011&DT=1
    Endoscopic bile reflux identified in 9.7% of all cases with gastrointestinal symptoms. […] Endoscopic bile reflux was common findings with young adults (30’s) at outpatients clinic. […] GB dysfunction were identified as significant risk factors for BRI (+) group.
  • #8 Bile Reflux Gastritis: Insights into Pathogenesis, Relevant Factors, Carcinomatous Risk, Diagnosis, and Management
    https://pmc.ncbi.nlm.nih.gov/articles/PMC9484982/
    Bile reflux gastritis (BRG), a kind of gastrointestinal disorder in clinical practice, is characterized by regurgitation and inflammation. However, lack of guidelines leads to simple cognition and even ignorance of this disease for clinicians. Primarily, making the pathogenesis of BRG clear contributes to a correct and general understanding of this disease for physicians. […] In terms of its prevalence, a study including 804 cases where there was an endoscopic examination for abdominal pain found bile reflux was seen in 23.9% patients. Another research observed that the prevalence of BRG was 16.7% and 61.8% in the control group, who had never undergone any biliary interventions and the postcholecystectomy group who had undergone cholecystectomy. […] The prevalence of DGER among all GERD patients ranged from 10% to 97%.
  • #9 Prevalence of bile reflux in gastroesophageal reflux disease patients not responsive to proton pump inhibitors
    https://pmc.ncbi.nlm.nih.gov/articles/PMC2653330/
    AIM: To determine the prevalence and characteristics of bile reflux in gastroesophageal reflux disease (GERD) patients with persistent symptoms who are non-responsive to medical therapy. […] The overall prevalence of bile reflux in non-responsive patients was 68.7%. […] Our findings also showed that a high percentage of GERD patients poorly responsive to PPIs have biliary reflux. We found that a high percentage (53.3%) of non-esophagitic GERD patients had pathologic bile reflux, increasing to 70% in esophagitic patients. […] This study clearly shows that the high percentage of patients poorly responsive to PPI therapy may result from poor control of DGERD. Many patients without esophagitis have simultaneous acid and bile reflux, which increases with increasing esophagitis grade.
  • #10 Prevalence of bile reflux in gastroesophageal reflux disease patients not responsive to proton pump inhibitors
    https://www.wjgnet.com/1007-9327/full/v15/i3/334.htm
    Prevalence of bile reflux in gastroesophageal reflux disease patients not responsive to proton pump inhibitors. […] The high percentage of patients poorly responsive to PPI therapy may result from poor control of duodenogastroesophageal reflux. […] Many patients without esophagitis have simultaneous acid and bile reflux, which increases with increasing esophagitis grade. […] A high percentage of GERD patients poorly responsive to PPIs have biliary reflux. […] The global prevalence of patients non-responsive to PPI therapy was 68.7%.
  • #11 Bile Reflux: Symptoms, Treatment, Causes & What It Is
    https://my.clevelandclinic.org/health/diseases/22056-bile-reflux
    Bile reflux is not thought to be common in otherwise healthy individuals. […] Bile reflux is most commonly recognized as a complication of surgery, particularly stomach surgery that bypasses, damages or replaces the pyloric valve. […] Bile (or non-acid) reflux is not common, but its a known complication of certain surgeries.
  • #12 Bile Reflux: Clinical Considerations – Gastroenterology Advisor
    https://www.gastroenterologyadvisor.com/features/tips-for-distinguishing-and-treating-biliary-reflux/
    Biliary reflux is difficult, yet important, to distinguish from acid reflux, in order to ensure proper treatment for these patients. […] In certain patients with bile reflux, it has been postulated that a weak or widely patent pylorus could predispose patients to this condition. […] Bile reflux may also be more common in patients with motility disorders, especially in those whose gastric or duodenal motility is reduced, including certain patients with type 2 diabetes mellitus or those taking chronic opioid medications. […] Patients who have undergone gastric surgeries where the pylorus is bypassed or disrupted may be predisposed to developing bile reflux as well. […] Additional risk factors include gallbladder dysfunction, cholecystectomy (CCY), and biliary sphincterotomy. […] Bile reflux is often seen in patients with Barrett esophagus (BE) and severe esophagitis, both of which can be identified during an esophagoduodenoscopy (EGD).
  • #13 Does Bile Reflux Increase Following Cholecystectomy? – Houston Heartburn and Reflux Center
    https://houstonheartburn.com/does-bile-reflux-increase-following-cholecystectomy/
    “Gastroesophageal Mucosal Injury after Cholecystectomy: An Indication for Surveillance?” is a new study published by T. Walsh et al in the current issue of JACS (Journal of the American College of Surgeons). The authors evaluate the incidence of stomach bile pooling detected by endoscopy in patients before and after cholecystectomy. They further measure the bile reflux index, cellular proliferation marker Ki67 and tumor-suppressor gene p53 in biopsies taken from the gastro-esophageal junction and gastric antrum. The analysis show that cholecystectomy increases the incidence of bile reflux and bile induced damage of gastric and esophageal mucosa. Chronic bile induced esophagitis and gastritis increase the incidence of gastric and esophageal cancer. […] This study shows that cholecystectomy increases the risk of bile reflux and esophago-gastric mucosa injury. I suspect the risk of bile reflux and mucosal injury is highest in GERD patients who undergo an unindicated cholecystectomy.
  • #14 Bile reflux: Symptoms, causes, treatment and more
    https://www.medicalnewstoday.com/articles/bile-reflux
    Bile reflux tends to be uncommon in people who do not have any health problems, but it is a well-known complication of certain surgeries. […] Bile reflux can happen for the following reasons: as a complication of surgery, such as bariatric or gallbladder surgery. […] Bile reflux usually requires medications and, sometimes, surgery. If left untreated, bile reflux can irritate the GI tract and increase the risk of complications.
  • #15 Bile Reflux: Clinical Considerations – Gastroenterology Advisor
    https://www.gastroenterologyadvisor.com/features/tips-for-distinguishing-and-treating-biliary-reflux/
    Biliary reflux is difficult, yet important, to distinguish from acid reflux, in order to ensure proper treatment for these patients. […] In certain patients with bile reflux, it has been postulated that a weak or widely patent pylorus could predispose patients to this condition. […] Bile reflux may also be more common in patients with motility disorders, especially in those whose gastric or duodenal motility is reduced, including certain patients with type 2 diabetes mellitus or those taking chronic opioid medications. […] Patients who have undergone gastric surgeries where the pylorus is bypassed or disrupted may be predisposed to developing bile reflux as well. […] Additional risk factors include gallbladder dysfunction, cholecystectomy (CCY), and biliary sphincterotomy. […] Bile reflux is often seen in patients with Barrett esophagus (BE) and severe esophagitis, both of which can be identified during an esophagoduodenoscopy (EGD).
  • #16 KoreaMed Synapse
    https://synapse.koreamed.org/articles/1058566
    Endoscopic bile reflux identified in 9.7% of all cases with gastrointestinal symptoms. […] Endoscopic bile reflux was common findings with young adults (30’s) at outpatients clinic. […] Bile reflux also had distinguishable ultra-structural changes identifiable by EM. […] GB dysfunction were identified as significant risk factors for BRI (+) group. […] The BRI (+) group had more old age, GB dysfunction than BRI (-) group. […] The BRI (+) group correlated with GB dysfunction (OR, 2.41; 95% CI, 0.62 to 9.31). […] Endoscopic bile reflux (9.7%) is a very common disease encountered in the outpatients clinic. It was found to be common in young adults (30’s) and more predominant in females. […] Bile reflux inhibited colonization of H. pylori in the stomach. […] BRI (+) group had more old age and GB dysfunction than BRI (-) group.
  • #17 Should I Be Worried About Bile Reflux?
    https://minimallyinvasivesurgeryfl.com/what-is-bile-reflux-and-do-i-need-to-worry-about-it/
    Bile reflux most often occurs after gallbladder removal or cholecystectomy. […] If bile pushes back into the stomach for any number of reasons, anatomical or technical, this is known as bile reflux. […] Even bariatric procedures can cause bile reflux. […] These advances have dramatically reduced the incidence and severity of bile reflux. […] Only when bile begins to reflux into the esophagus do patients experience significant symptoms. […] Unfortunately, while the symptoms of bile reflux may feel the same as gastric reflux, ultimately, antacids and acid-blocking medications do not work when acid is not the main concern. […] If you have recently had a cholecystectomy and have new or worsened GERD, you should speak to your doctor. […] Ultimately, treatment for bile reflux is very successful, and most patients experience significant relief after their procedure.
  • #18 KoreaMed Synapse
    https://synapse.koreamed.org/articles/1058566
    Endoscopic bile reflux identified in 9.7% of all cases with gastrointestinal symptoms. […] Endoscopic bile reflux was common findings with young adults (30’s) at outpatients clinic. […] Bile reflux also had distinguishable ultra-structural changes identifiable by EM. […] GB dysfunction were identified as significant risk factors for BRI (+) group. […] The BRI (+) group had more old age, GB dysfunction than BRI (-) group. […] The BRI (+) group correlated with GB dysfunction (OR, 2.41; 95% CI, 0.62 to 9.31). […] Endoscopic bile reflux (9.7%) is a very common disease encountered in the outpatients clinic. It was found to be common in young adults (30’s) and more predominant in females. […] Bile reflux inhibited colonization of H. pylori in the stomach. […] BRI (+) group had more old age and GB dysfunction than BRI (-) group.
  • #19 Bile Reflux Gastropathy and Functional Dyspepsia
    https://www.jnmjournal.org/journal/view.html?doi=10.5056/jnm20102
    Bile reflux gastropathy is associated with functional dyspepsia and causes more severe symptoms. Cholecystectomy predisposes to BG and abnormal pain, and could contribute to the pathogenesis of functional dyspepsia. […] Cholecystectomy may serve as a risk factor for bile reflux into the stomach. […] To examine if cholecystectomy is a risk factor for BG and functional dyspepsia, we performed multivariate regression modeling comparing BG group (n = 90) vs NBG + NG group (n = 172). This revealed that cholecystectomy (OR, 6.60; 95% CI, 1.87-23.30; P = 0.003; Model A) was significantly associated with BG. […] Cholecystectomy appears to be a significant risk factor for the development of BG.
  • #20 Bile Reflux: Symptoms, Treatment, Causes & What It Is
    https://my.clevelandclinic.org/health/diseases/22056-bile-reflux
    Bile reflux is not thought to be common in otherwise healthy individuals. […] Bile reflux is most commonly recognized as a complication of surgery, particularly stomach surgery that bypasses, damages or replaces the pyloric valve. […] Bile (or non-acid) reflux is not common, but its a known complication of certain surgeries.
  • #21
    https://link.springer.com/article/10.1023/A:1021069508731
    Duodenogastric reflux (DGR) was assessed with 24-hour gastric bilirubin monitoring in 345 patients (219 men; 49 13 years) with foregut symptoms and 41 healthy subjects (24 men, 28 5 years). […] DGR was highest following Billroth II gastric resection (60 24%, N = 15). Patients after cholecystectomy (28 25%, N = 25), patients with gastroesophageal reflux disease (24 24%, N = 199), and patients with nonulcer dyspepsia (23 21%, N = 61) had a significantly higher exposure to DGR than healthy subjects (7 8%, P 0.0001). […] In conclusion, gastric bilirubin monitoring is useful for the assessment of DGR specifically in symptomatic patients following gastric resection. Increased amounts of DGR may further be of clinical importance in patients with reflux disease or nonulcer dyspepsia and following cholecystectomy.
  • #22 Biliary reflux after bariatric surgery and after gastroesophageal surgery for gastroesophageal reflux disease – Marabotto – Digestive Medicine Research
    https://dmr.amegroups.org/article/view/9258/html
    Biliary reflux refers to the ascent of duodenal fluid, biliary and pancreatic secretions into the stomach and esophagus. It is a primitive phenomenon or it can be secondary to gastric or biliary surgery. In particular, biliary reflux seems common after bariatric surgeries with, however, unknown incidence. Current data show that the prevalence of biliary reflux was higher after minigastric bypass as compared to the other bariatric surgeries. […] The prevalence of biliary reflux after bariatric surgeries has been heterogeneously reported in a number of studies. Lasheen et al. assessed the prevalence of bile reflux gastritis and esophagitis in over 40 patients after MGB and found that 20% of them had bile reflux as diagnosed by gastric pouch biopsy and gastric aspirate examination. […] The reported prevalence of biliary reflux was higher after MGB as compared to the other bariatric surgeries and when HIDA was used to measure biliary reflux as compared to endoscopy and gastric pouch biopsies.
  • #23 Biliary reflux after bariatric surgery and after gastroesophageal surgery for gastroesophageal reflux disease – Marabotto – Digestive Medicine Research
    https://dmr.amegroups.org/article/view/9258/html
    Biliary reflux refers to the ascent of duodenal fluid, biliary and pancreatic secretions into the stomach and esophagus. It is a primitive phenomenon or it can be secondary to gastric or biliary surgery. In particular, biliary reflux seems common after bariatric surgeries with, however, unknown incidence. Current data show that the prevalence of biliary reflux was higher after minigastric bypass as compared to the other bariatric surgeries. […] The prevalence of biliary reflux after bariatric surgeries has been heterogeneously reported in a number of studies. Lasheen et al. assessed the prevalence of bile reflux gastritis and esophagitis in over 40 patients after MGB and found that 20% of them had bile reflux as diagnosed by gastric pouch biopsy and gastric aspirate examination. […] The reported prevalence of biliary reflux was higher after MGB as compared to the other bariatric surgeries and when HIDA was used to measure biliary reflux as compared to endoscopy and gastric pouch biopsies.
  • #24 Once in a Bile — the Incidence of Bile Reflux Post-Bariatric Surgery. | EBSCOhost
    https://search.ebscohost.com/login.aspx?direct=true&profile=ehost&scope=site&authtype=crawler&jrnl=09608923&AN=156152475&h=2GJSF1PJyF73OrmExRmYCU%2BoFWw%2BjcMGvN%2BzHbLqzHqmgzAxks37ppS5Hp6Rsr8U54CuaRl3y9HmsOarH0GluA%3D%3D&crl=c
    Once in a Bile — the Incidence of Bile Reflux Post-Bariatric Surgery. […] Purpose: Excellent metabolic improvement following one anastomosis gastric bypass (OAGB) remains compromised by the risk of esophageal bile reflux and theoretical carcinogenic potential. […] No 'gold standard’ investigation exists for esophageal bile reflux, with diverse methods employed in the few studies evaluating it post-obesity surgery. […] As such, data on the incidence and severity of esophageal bile reflux is limited, with comparative studies lacking. […] Results: Gastric reflux of bile was identified by biliary scintigraphy in 14 OAGB (70%), one RYGB (5%) and four SG participants (31%), with a mean of 2.9% (SD 1.5) reflux (% of total radioactivity). […] One participant (OAGB) demonstrated esophageal bile reflux. […] Conclusion: Despite high incidence of gastric bile reflux post-OAGB, esophageal bile reflux is rare. […] With scarce literature of tumour development post-OAGB, frequent low-volume gastric bile reflux likely bears little clinical consequence; however, longer-term studies are needed.
  • #25 Bile Reflux following Single-Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy (SADI-S) and its Surgical Treatment : Bariatric Times
    https://bariatrictimes.com/bile-reflux-sadis-surgical-treatment/
    Bile reflux following the single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) procedure is rare. The reported incidence of bile reflux following the SADI-S procedure is 0.1 percent. […] Bile reflux can occur months to years after SADI-S. If it occurs, it can be fixed easily with surgical treatment.
  • #26 Gastroesophageal Reflux Disease: Practice Essentials, Background, Anatomy
    https://emedicine.medscape.com/article/176595-overview
    Western dietary habits have made GERD a common disease. The prevalence of GERD in Western populations is estimated to be 10-20%, whereas it is about 2.5-17.0% in Asian populations. […] Richter and associates reported that 25%-40% of Americans experience symptomatic GERD at some point. Approximately 7%-10% of Americans experience symptoms of GERD on a daily basis. Because many individuals control their symptoms with over-the-counter (OTC) medications and without consulting a medical professional, the actual number of individuals with GERD is probably higher. […] No sexual predilection exists: GERD is as common in men as in women. However, the male-to-female incidence ratio for esophagitis is 2:1-3:1. The male-to-female incidence ratio for Barrett esophagus is 10:1. White males are at a greater risk for Barrett esophagus and adenocarcinoma than other populations. […] GERD occurs in all age groups. The prevalence of GERD increases in people older than 40 years.
  • #27 Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review | Gut
    https://gut.bmj.com/content/63/6/871
    Objective To update the findings of the 2005 systematic review of population-based studies assessing the epidemiology of gastro-oesophageal reflux disease (GERD). […] Results 16 studies of GERD epidemiology published since the original review were found to be suitable for inclusion (15 reporting prevalence and one reporting incidence), and were added to the 13 prevalence and two incidence studies found previously. The range of GERD prevalence estimates was 18.1%27.8% in North America, 8.8%25.9% in Europe, 2.5%7.8% in East Asia, 8.7%33.1% in the Middle East, 11.6% in Australia and 23.0% in South America. Incidence per 1000 person-years was approximately 5 in the overall UK and US populations, and 0.84 in paediatric patients aged 117years in the UK. Evidence suggests an increase in GERD prevalence since 1995 (p0.0001), particularly in North America and East Asia. […] Conclusions GERD is prevalent worldwide, and disease burden may be increasing. Prevalence estimates show considerable geographic variation, but only East Asia shows estimates consistently lower than 10%.
  • #28 Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review | Gut
    https://gut.bmj.com/content/63/6/871
    Objective To update the findings of the 2005 systematic review of population-based studies assessing the epidemiology of gastro-oesophageal reflux disease (GERD). […] Results 16 studies of GERD epidemiology published since the original review were found to be suitable for inclusion (15 reporting prevalence and one reporting incidence), and were added to the 13 prevalence and two incidence studies found previously. The range of GERD prevalence estimates was 18.1%27.8% in North America, 8.8%25.9% in Europe, 2.5%7.8% in East Asia, 8.7%33.1% in the Middle East, 11.6% in Australia and 23.0% in South America. Incidence per 1000 person-years was approximately 5 in the overall UK and US populations, and 0.84 in paediatric patients aged 117years in the UK. Evidence suggests an increase in GERD prevalence since 1995 (p0.0001), particularly in North America and East Asia. […] Conclusions GERD is prevalent worldwide, and disease burden may be increasing. Prevalence estimates show considerable geographic variation, but only East Asia shows estimates consistently lower than 10%.
  • #29 Management of Bile Reflux – Gastroenterology & Hepatology
    https://www.gastroenterologyandhepatology.net/archives/march-2013/management-of-bile-reflux/
    Bile reflux is very infrequent in healthy individuals. This condition is more severe in patients with gastroesophageal reflux disease, particularly those with severe esophagitis and/or Barrett esophagus. […] It has been shown that patients with more bile reflux have more severe esophageal mucosal damage, so there is a clear correlation between the amount of bile reflux and the severity of distal esophageal inflammation. In fact, patients with the most severe degree of gastroesophageal inflammation, Barrett esophagus, are those with the largest amount of bile reflux. Thus, the importance of bile reflux has to do primarily with the severity of the damage of the esophageal mucosa, the development of Barrett mucosa, and, potentially, the risk of cancer. It is known that the more bile reflux a patient has, the higher the risk of Barrett esophagus development; both in vivo and in vitro studies have shown a link between bile that is in contact with esophageal mucosa and changes in the mucosa that are compatible with Barrett esophagus.
  • #30 Management of Bile Reflux – Gastroenterology & Hepatology
    https://www.gastroenterologyandhepatology.net/archives/march-2013/management-of-bile-reflux/
    Bile reflux is very infrequent in healthy individuals. This condition is more severe in patients with gastroesophageal reflux disease, particularly those with severe esophagitis and/or Barrett esophagus. […] It has been shown that patients with more bile reflux have more severe esophageal mucosal damage, so there is a clear correlation between the amount of bile reflux and the severity of distal esophageal inflammation. In fact, patients with the most severe degree of gastroesophageal inflammation, Barrett esophagus, are those with the largest amount of bile reflux. Thus, the importance of bile reflux has to do primarily with the severity of the damage of the esophageal mucosa, the development of Barrett mucosa, and, potentially, the risk of cancer. It is known that the more bile reflux a patient has, the higher the risk of Barrett esophagus development; both in vivo and in vitro studies have shown a link between bile that is in contact with esophageal mucosa and changes in the mucosa that are compatible with Barrett esophagus.
  • #31 Prevalence of bile reflux in gastroesophageal reflux disease patients not responsive to proton pump inhibitors
    https://pmc.ncbi.nlm.nih.gov/articles/PMC2653330/
    AIM: To determine the prevalence and characteristics of bile reflux in gastroesophageal reflux disease (GERD) patients with persistent symptoms who are non-responsive to medical therapy. […] The overall prevalence of bile reflux in non-responsive patients was 68.7%. […] Our findings also showed that a high percentage of GERD patients poorly responsive to PPIs have biliary reflux. We found that a high percentage (53.3%) of non-esophagitic GERD patients had pathologic bile reflux, increasing to 70% in esophagitic patients. […] This study clearly shows that the high percentage of patients poorly responsive to PPI therapy may result from poor control of DGERD. Many patients without esophagitis have simultaneous acid and bile reflux, which increases with increasing esophagitis grade.
  • #32 Bile Reflux: Clinical Considerations – Gastroenterology Advisor
    https://www.gastroenterologyadvisor.com/features/tips-for-distinguishing-and-treating-biliary-reflux/
    Certain patients may develop biliary reflux based on having an acid-bile pocket in the proximal part of the stomach; this leads to a collection of bile and may predispose the patient to esophageal reflux. […] Identification of biliary reflux is important, as patients experiencing this can have more severe mucosal damage in the esophagus, including BE. […] A study conducted by Dixon et al found that patients with BE had more evidence of bile related gastritis compared with those reported as having only GERD or nonulcer dyspepsia. […] This study, along with others, raises the question as to whether there is a carcinogenic role of bile reflux. […] Therefore, patients with evidence of bile reflux should be considered for more aggressive therapy, in the hopes of potentially preventing negative sequelae such as BE. […] The authors concluded that duodeno-gastric bile reflux was present in at least 1/3 of patients with functional dyspepsia.
  • #33 Prevalence of bile reflux in gastroesophageal reflux disease patients not responsive to proton pump inhibitors
    https://pmc.ncbi.nlm.nih.gov/articles/PMC2653330/
    AIM: To determine the prevalence and characteristics of bile reflux in gastroesophageal reflux disease (GERD) patients with persistent symptoms who are non-responsive to medical therapy. […] The overall prevalence of bile reflux in non-responsive patients was 68.7%. […] Our findings also showed that a high percentage of GERD patients poorly responsive to PPIs have biliary reflux. We found that a high percentage (53.3%) of non-esophagitic GERD patients had pathologic bile reflux, increasing to 70% in esophagitic patients. […] This study clearly shows that the high percentage of patients poorly responsive to PPI therapy may result from poor control of DGERD. Many patients without esophagitis have simultaneous acid and bile reflux, which increases with increasing esophagitis grade.
  • #34 Prevalence of bile reflux in gastroesophageal reflux disease patients not responsive to proton pump inhibitors
    https://www.wjgnet.com/1007-9327/full/v15/i3/334.htm
    Prevalence of bile reflux in gastroesophageal reflux disease patients not responsive to proton pump inhibitors. […] The high percentage of patients poorly responsive to PPI therapy may result from poor control of duodenogastroesophageal reflux. […] Many patients without esophagitis have simultaneous acid and bile reflux, which increases with increasing esophagitis grade. […] A high percentage of GERD patients poorly responsive to PPIs have biliary reflux. […] The global prevalence of patients non-responsive to PPI therapy was 68.7%.
  • #35 Prevalence of bile reflux in gastroesophageal reflux disease patients not responsive to proton pump inhibitors
    https://pmc.ncbi.nlm.nih.gov/articles/PMC2653330/
    AIM: To determine the prevalence and characteristics of bile reflux in gastroesophageal reflux disease (GERD) patients with persistent symptoms who are non-responsive to medical therapy. […] The overall prevalence of bile reflux in non-responsive patients was 68.7%. […] Our findings also showed that a high percentage of GERD patients poorly responsive to PPIs have biliary reflux. We found that a high percentage (53.3%) of non-esophagitic GERD patients had pathologic bile reflux, increasing to 70% in esophagitic patients. […] This study clearly shows that the high percentage of patients poorly responsive to PPI therapy may result from poor control of DGERD. Many patients without esophagitis have simultaneous acid and bile reflux, which increases with increasing esophagitis grade.
  • #36 Approach to refractory gastroesophageal reflux disease in adults – UpToDate
    https://www.uptodate.com/contents/approach-to-refractory-gastroesophageal-reflux-disease-in-adults
    Up to 50 percent of patients with gastroesophageal reflux disease (GERD) fail to respond symptomatically, either partially or completely, to proton pump inhibitors (PPIs) [3-7]. Most patients with GERD who do not respond to a PPI have either nonerosive reflux (NERD) or functional heartburn. In patients with NERD, the pooled symptomatic response rate to PPI once daily at four weeks is 37 percent [8,9]. In contrast, in patients with erosive esophagitis, which accounts for 30 to 40 percent of the GERD population, the pooled symptomatic response rate is 56 percent [8].
  • #37 Approach to refractory gastroesophageal reflux disease in adults – UpToDate
    https://www.uptodate.com/contents/approach-to-refractory-gastroesophageal-reflux-disease-in-adults
    Up to 50 percent of patients with gastroesophageal reflux disease (GERD) fail to respond symptomatically, either partially or completely, to proton pump inhibitors (PPIs) [3-7]. Most patients with GERD who do not respond to a PPI have either nonerosive reflux (NERD) or functional heartburn. In patients with NERD, the pooled symptomatic response rate to PPI once daily at four weeks is 37 percent [8,9]. In contrast, in patients with erosive esophagitis, which accounts for 30 to 40 percent of the GERD population, the pooled symptomatic response rate is 56 percent [8].
  • #38 Biliary reflux – Wikipedia
    https://en.wikipedia.org/wiki/Biliary_reflux
    Bile reflux is very infrequent in healthy individuals. […] Bile acids are frequently present in the gastroesophageal refluxate, and thus can cause inflammatory and neoplastic changes in the upper aerodigestive tract. […] Bile reflux appears to be a causal factor in human hypopharyngeal squamous cell carcinoma.
  • #39 Management of Bile Reflux – Gastroenterology & Hepatology
    https://www.gastroenterologyandhepatology.net/archives/march-2013/management-of-bile-reflux/
    However, there is no need for patients with bile reflux to undergo special monitoring or take any prophylactic measures (apart from treatment of gastroesophageal reflux disease) unless they already have Barrett esophagus. Even in this case, endoscopic surveillance is controversial if the Barrett mucosa shows no signs of dysplasia. […] There are 3 main lines of research in this area. One is related to the impact of bile acids and bile salts in the esophageal mucosa and the development of Barrett esophagus and cancer. The second line of research involves the role of bile reflux in extraesophageal syndromes related to reflux (eg, the development of respiratory disorders associated with reflux). There is some evidence that the presence of bile in the aspiration of refluxate into the airways might be very important in the development of respiratory disorders. This is a marker of aspiration as well as a very important inflammatory component that can trigger inflammation. This is true for patients with reflux who have undergone lung transplantation and patients with cystic fibrosis. Thus, the appearance of bile in respiratory secretions is not only considered a marker, but it can also be pathogenic in the respiratory disorder. The third line of research involves the role of bile in the pathogenesis of nonerosive reflux disease and symptoms. It is known that patients who have persistent symptoms such as heartburn or regurgitation may have refluxate that contains bile acid despite receiving proton pump inhibitor therapy (because proton pump inhibitors do not reduce the presence of bile acid). Bile acids might have an impact on the esophageal mucosa of patients with nonerosive reflux disease and might be related to the persistence of symptoms in these patients.
  • #40 Bile Reflux Gastritis: Insights into Pathogenesis, Relevant Factors, Carcinomatous Risk, Diagnosis, and Management
    https://pmc.ncbi.nlm.nih.gov/articles/PMC9484982/
    Nowadays, as a kind of gastrointestinal disorders, BRG is deemed as a risk factor for gastric cancer but not taken seriously in gastroenterology department. […] More and more studies have established that bile reflux gastritis is closely associated with the development of precancerous lesions and gastric cancer (GC) and may be an independent risk factor for GC. A multicenter, cross-sectional, and observational study conducted in five centers in China concluded that independent risk factors for cancerous gastric lesions were the grade of bile reflux, patient’s age, dietary habits, and family history of GC. […] The mechanism of GC induced by bile reflux is still unclear. […] The diagnosis of bile reflux gastritis is still challenging for its atypical clinical symptoms and nonspecific auxiliary examinations.
  • #41 Bile Reflux Gastritis: Insights into Pathogenesis, Relevant Factors, Carcinomatous Risk, Diagnosis, and Management
    https://pmc.ncbi.nlm.nih.gov/articles/PMC9484982/
    Nowadays, as a kind of gastrointestinal disorders, BRG is deemed as a risk factor for gastric cancer but not taken seriously in gastroenterology department. […] More and more studies have established that bile reflux gastritis is closely associated with the development of precancerous lesions and gastric cancer (GC) and may be an independent risk factor for GC. A multicenter, cross-sectional, and observational study conducted in five centers in China concluded that independent risk factors for cancerous gastric lesions were the grade of bile reflux, patient’s age, dietary habits, and family history of GC. […] The mechanism of GC induced by bile reflux is still unclear. […] The diagnosis of bile reflux gastritis is still challenging for its atypical clinical symptoms and nonspecific auxiliary examinations.
  • #42 Medical management of acid/bile reflux before, during and after endoscopic therapy for Barrett’s esophagus: a narrative review – Jaswani – Annals of Esophagus
    https://aoe.amegroups.org/article/view/5859/html
    Bile reflux or duodenogastric reflux has been proposed in the etiology of BE as bile acids have been found in the refluxate of patients with BE. It has been suggested that bile acids may exert their effects on the esophageal mucosa through cytotoxic pathways and upregulation of proto-oncogene and c-myc resulting in inflammation and contributing to the inflammation-cancer cascade. Bile acids become non- ionized at acidic pH, enters cells and exert mucosal injury and inflammation. The effect of bile acid has been found to be most significant when combined with gastric acid. […] Inadequate acid suppression defined by impedance-pH monitoring is a modifiable risk factor and increases the risk of recurrence of intestinal metaplasia (IM) after EET. Ongoing distal esophageal reflux, both acid and non-acid is also associated with incomplete response to EET. This observation highlights the importance of aggressive pharmacologic acid suppression and also reminds us of the role of lifestyle modifications in decreasing distal esophageal reflux exposure both during and after the EET period.
  • #43 Screening for Bile Reflux Could Help Identify Barrett Esophagus
    https://www.gastroenterologyadvisor.com/news/screening-for-bile-reflux-could-help-identify-barrett-esophagus/
    Endoscopic evidence of bile reflux could serve as a predictor of Barrett esophagus development. […] Endoscopic evidence of bile reflux is associated with the presence of Barrett esophagus (BE), according to a study published in Digestive and Liver Disease. […] This endoscopic finding might therefore help identify patients at risk of developing BE and would benefit endoscopy surveillance. […] Evidence of bile reflux was associated with the presence of BE (OR, 5.65; 95% CI, 4.71-6.76; P .001). […] The researchers concluded, This endoscopic finding might, therefore, help identify patients at risk of developing BE and would benefit endoscopy surveillance.
  • #44 Medical management of acid/bile reflux before, during and after endoscopic therapy for Barrett’s esophagus: a narrative review – Jaswani – Annals of Esophagus
    https://aoe.amegroups.org/article/view/5859/html
    Bile reflux or duodenogastric reflux has been proposed in the etiology of BE as bile acids have been found in the refluxate of patients with BE. It has been suggested that bile acids may exert their effects on the esophageal mucosa through cytotoxic pathways and upregulation of proto-oncogene and c-myc resulting in inflammation and contributing to the inflammation-cancer cascade. Bile acids become non- ionized at acidic pH, enters cells and exert mucosal injury and inflammation. The effect of bile acid has been found to be most significant when combined with gastric acid. […] Inadequate acid suppression defined by impedance-pH monitoring is a modifiable risk factor and increases the risk of recurrence of intestinal metaplasia (IM) after EET. Ongoing distal esophageal reflux, both acid and non-acid is also associated with incomplete response to EET. This observation highlights the importance of aggressive pharmacologic acid suppression and also reminds us of the role of lifestyle modifications in decreasing distal esophageal reflux exposure both during and after the EET period.
  • #45 Bile reflux after bariatric surgery | Cirugía Española (English Edition)
    https://www.elsevier.es/es-revista-cirugia-espanola-english-edition–436-articulo-bile-reflux-after-bariatric-surgery-S2173507723002235
    The growing epidemic of obesity and the increase in weight loss surgery has led to a resurgence of interest in biliary reflux because anatomical alterations may be refluxogenic. […] HIDA scan is the least invasive scan with good patient tolerability, sensitivity and reproducibility for the diagnosis of biliary reflux. […] Patients with more advanced oesophageal lesions have a higher degree of duodenal reflux. It has been shown in animal models and in vitro that there is more Barrett’s and dysplasia with duodenal reflux. […] Prospective trials on OAGB should include endoscopy preoperatively and at 5-year intervals, to have data on the real effects of bile exposure on the gastric reservoir and oesophagus. […] In the latest systematic review analysing the prevalence, symptoms, lesions and treatment of DGOR, several studies both in vitro and in vivo have implicated duodenal contents in the pathogenesis of oesophagogastric lesions.
  • #46 Roles and action mechanisms of bile acid-induced gastric intestinal metaplasia: a review | Cell Death Discovery
    https://www.nature.com/articles/s41420-022-00962-1
    Long-term exposure to bile acids has been shown to increase the risk of transition from normal mucosa to IM, and eventually leads to the development of GC over many years. […] However, there are no clear studies on whether bile-reflux monitoring can be used to monitor and delay the development of gastric IM. […] Currently, there is a controversial debate whether or not gastric IM is reversible. […] It is generally believed that H. pylori eradication before the occurrence of gastric IM can help control gastritis, while once gastric IM is established, H. pylori eradication cannot reverse gastric IM but can help prevent or delay the progression of gastric IM. […] Therefore, more evidence is needed to determine whether H. pylori eradication can delay and reverse IM. […] In summary, the symptoms caused by bile reflux can be alleviated by drugs and surgery. However, there are no high-quality studies on whether the treatment of bile reflux can reverse IM.
  • #47 Bile reflux after bariatric surgery | Cirugía Española (English Edition)
    https://www.elsevier.es/es-revista-cirugia-espanola-english-edition–436-articulo-bile-reflux-after-bariatric-surgery-S2173507723002235
    Recent trials that have attempted to directly treat bile as a component of gastro-oesophageal reflux disease (GORD) have demonstrated an improvement in symptoms and lesions in these patients. […] A new therapy, called IW-3718 (Colesevelam), binds and neutralises bile in the stomach, decreasing the volume of reflux and improving endoscopic imaging in 87% of cases, while also increasing muscle tissue relaxation. […] Despite the known histopathological links between oesophageal mucosal exposure to bile and carcinogenesis, only two cases of gastric pouch/distal oesophageal malignancy have been described in 20 years since the advent of OAGB. […] These results suggest that prospective trials of OAGB should include endoscopy preoperatively and at 5-year intervals to provide data on the true effects of bile exposure in the gastric reservoir and oesophagus. […] The HIDA scan is a sensitive measure of remnant pathology and is a readily available non-invasive test.
  • #48 Biliary reflux – Wikipedia
    https://en.wikipedia.org/wiki/Biliary_reflux
    Bile reflux is very infrequent in healthy individuals. […] Bile acids are frequently present in the gastroesophageal refluxate, and thus can cause inflammatory and neoplastic changes in the upper aerodigestive tract. […] Bile reflux appears to be a causal factor in human hypopharyngeal squamous cell carcinoma.
  • #49 Bile reflux and hypopharyngeal cancer (Review)
    https://www.spandidos-publications.com/10.3892/or.2021.8195
    Recent in vitro and in vivo data provide evidence on bile reflux-associated hypopharyngeal carcinogenesis. […] In parallel, acidic bile-induced constitutive activation of NF-B can promote oncogenic mRNA and miRNA phenotypes, contributing to the proliferation of mutated cells and thus giving rise to the malignant transformation of the exposed HM.
  • #50 Mayo Clinic Health Library – Bile reflux | Swiss Medical Network
    https://www.swissmedical.net/fr/healtcare-library/con-20370100
    Bile reflux occurs when bile a digestive liquid produced in your liver backs up (refluxes) into your stomach and, in some cases, into the tube that connects your mouth and stomach (esophagus). […] Bile reflux may accompany the reflux of stomach acid (gastric acid) into your esophagus. Gastric reflux may lead to gastroesophageal reflux disease (GERD), a potentially serious problem that causes irritation and inflammation of esophageal tissue. […] Bile reflux gastritis has been linked to stomach cancer. The combination of bile reflux and acid reflux also increases the risk of the following complications: […] Bile is often suspected of contributing to GERD when people respond incompletely or not at all to powerful acid-suppressant medications. […] In animal studies, bile reflux alone has been shown to cause cancer of the esophagus.
  • #51 Bile Reflux Gastritis: Insights into Pathogenesis, Relevant Factors, Carcinomatous Risk, Diagnosis, and Management
    https://pmc.ncbi.nlm.nih.gov/articles/PMC9484982/
    Nowadays, as a kind of gastrointestinal disorders, BRG is deemed as a risk factor for gastric cancer but not taken seriously in gastroenterology department. […] More and more studies have established that bile reflux gastritis is closely associated with the development of precancerous lesions and gastric cancer (GC) and may be an independent risk factor for GC. A multicenter, cross-sectional, and observational study conducted in five centers in China concluded that independent risk factors for cancerous gastric lesions were the grade of bile reflux, patient’s age, dietary habits, and family history of GC. […] The mechanism of GC induced by bile reflux is still unclear. […] The diagnosis of bile reflux gastritis is still challenging for its atypical clinical symptoms and nonspecific auxiliary examinations.
  • #52 Roles and action mechanisms of bile acid-induced gastric intestinal metaplasia: a review | Cell Death Discovery
    https://www.nature.com/articles/s41420-022-00962-1
    Gastric intestinal metaplasia (IM) is a precancerous lesion that increases the risk of subsequent gastric cancer (GC) development. […] However, more and more studies have shown that chronic inflammation of gastric mucosa caused by bile reflux is the key pathogenic factor of gastric IM. […] Accumulative evidence has revealed that bile reflux is associated with gastric IM and even carcinoma. […] Bile reflux into the stomach can not only directly stimulate the gastric mucosal barrier, but also regulate multiple downstream pathways to induce chronic inflammation of the gastric mucosa. […] Increasing evidence has demonstrated that bile reflux is thought to be associated with atrophic gastritis, IM, dysplasia, and even carcinogenesis. […] The mechanism of bile acid-induced gastric IM in the stomach is not clear and needs further research.
  • #53 Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review | Gut
    https://gut.bmj.com/content/63/6/871
    Objective To update the findings of the 2005 systematic review of population-based studies assessing the epidemiology of gastro-oesophageal reflux disease (GERD). […] Results 16 studies of GERD epidemiology published since the original review were found to be suitable for inclusion (15 reporting prevalence and one reporting incidence), and were added to the 13 prevalence and two incidence studies found previously. The range of GERD prevalence estimates was 18.1%27.8% in North America, 8.8%25.9% in Europe, 2.5%7.8% in East Asia, 8.7%33.1% in the Middle East, 11.6% in Australia and 23.0% in South America. Incidence per 1000 person-years was approximately 5 in the overall UK and US populations, and 0.84 in paediatric patients aged 117years in the UK. Evidence suggests an increase in GERD prevalence since 1995 (p0.0001), particularly in North America and East Asia. […] Conclusions GERD is prevalent worldwide, and disease burden may be increasing. Prevalence estimates show considerable geographic variation, but only East Asia shows estimates consistently lower than 10%.
  • #54 Reflux Esophagitis Pathology: Definition, Epidemiology, Etiology
    https://emedicine.medscape.com/article/1610393-overview
    GERD is prevalent worldwide. In the United States, studies have shown that approximately 18.1-27.8% of the population experiences GERD symptoms, which is consistent with other Western countries. […] Globally, the prevalence of GERD varies significantly, ranging from 2.5% to 7.8% in East Asia, 8.8% to 25.9% in Europe, and 8.7% to 33.1% in the Middle East. […] The global age-standardized prevalence rate of GERD has remained relatively stable, with an estimated 9574.45 per 100,000 population in 2019. […] Racial and ethnic differences in the prevalence of reflux esophagitis are also well reported in the literature. Studies from the United States and Europe show that White individuals have a higher prevalence of severe grades of esophagitis and Barrett’s esophagus (a complication of GERD) relative to Hispanics, Blacks, and Asians.
  • #55 Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis | Scientific Reports
    https://www.nature.com/articles/s41598-020-62795-1
    Although gastro-oesophageal reflux disease (GORD) is a common medical complaint, there is currently no consensus on the global prevalence of GORD. […] The global pooled prevalence of GORD was 13.98% and varied greatly according to region (12.88% in Latin America and the Caribbean to 19.55% in North America) and country (4.16% in China to 22.40% in Turkey). […] Using the United Nations 2017 Revision of World Population Prospects, the estimated number of individuals suffering from GORD globally is 1.03 billion. […] This systematic review and meta-analysis revealed that although a substantial proportion (13.98%) of the global population suffers from GORD, there are significant variations between regions and countries. […] A recent systematic review and meta-analysis conducted by Eusebi et al. 2017 included 108 studies and assessed the global prevalence of, and risk factors for, gastric reflux symptoms rather the prevalence of GORD.
  • #56 Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis | Scientific Reports
    https://www.nature.com/articles/s41598-020-62795-1
    Subjects with a moderate/high intake of carbonated drinks had a higher pooled prevalence of GORD than those with low/none intake (18.60% vs 14.54%, respectively). […] Pooling prevalence of GORD according to intake of coffee/tea revealed a higher GORD prevalence in subjects with a moderate/high intake of coffee/tea (21.02%) than those with a low/none intake (16.92%). […] This comprehensive systematic review has demonstrated the significant global burden of GORD with approximately 1.03 billion individuals suffering from the condition globally. […] It has also confirmed substantial variations in the pooled prevalence of GORD between regions and countries.
  • #57 Epidemiology of gastroesophageal reflux disease in Iran: a systematic review and meta-analysis | BMC Gastroenterology | Full Text
    https://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-020-01417-6
    A systematic review of longitudinal studies suggests that the incidence of GERD has increased in recent decades. If this trend continues, it may rapidly increase the serious complications of GERD, affect the patients quality of life, and increase the cost of health care systems. […] Increasing the GERD awareness to improve Iranian peoples health may be necessary. There is much information in Western cultures that can be generalized to an Iranian person but cannot match completely. Therefore, understanding the epidemiological effects of GERD in Iranian society can help healthcare professionals and policymakers take the next steps in creating the list of priorities for disease management.
  • #58 The Changing Epidemiology of Gastroesophageal Reflux Disease: Are Patients Getting Younger?
    https://www.jnmjournal.org/journal/view.html?doi=10.5056/jnm18140
    Gastroesophageal reflux disease (GERD) is a common disease globally with increasing prevalence and consequently greater burden on the Healthcare system. […] Over the last decade, there has been a significant increase in the proportion of younger patients with GERD, especially those within the age range of 30-39 years. […] The increase in GERD prevalence may be due to multiple factors such as older age, male sex, race, intake of analgesics, consumption of certain types of food and drinks, decrease in the prevalence of Helicobacter pylori infection, smoking, family history of GERD, high body mass index (BMI), and limited physical activity. […] As risk factors for GERD increasingly affect the general population, concerns have been raised that more young individuals will develop GERD and its potential consequences.
  • #59 The Changing Epidemiology of Gastroesophageal Reflux Disease: Are Patients Getting Younger?
    https://www.jnmjournal.org/journal/view.html?doi=10.5056/jnm18140
    Gastroesophageal reflux disease (GERD) is a common disease globally with increasing prevalence and consequently greater burden on the Healthcare system. […] Over the last decade, there has been a significant increase in the proportion of younger patients with GERD, especially those within the age range of 30-39 years. […] The increase in GERD prevalence may be due to multiple factors such as older age, male sex, race, intake of analgesics, consumption of certain types of food and drinks, decrease in the prevalence of Helicobacter pylori infection, smoking, family history of GERD, high body mass index (BMI), and limited physical activity. […] As risk factors for GERD increasingly affect the general population, concerns have been raised that more young individuals will develop GERD and its potential consequences.
  • #60 KoreaMed Synapse
    https://synapse.koreamed.org/articles/1058566
    Endoscopic bile reflux identified in 9.7% of all cases with gastrointestinal symptoms. […] Endoscopic bile reflux was common findings with young adults (30’s) at outpatients clinic. […] Bile reflux also had distinguishable ultra-structural changes identifiable by EM. […] GB dysfunction were identified as significant risk factors for BRI (+) group. […] The BRI (+) group had more old age, GB dysfunction than BRI (-) group. […] The BRI (+) group correlated with GB dysfunction (OR, 2.41; 95% CI, 0.62 to 9.31). […] Endoscopic bile reflux (9.7%) is a very common disease encountered in the outpatients clinic. It was found to be common in young adults (30’s) and more predominant in females. […] Bile reflux inhibited colonization of H. pylori in the stomach. […] BRI (+) group had more old age and GB dysfunction than BRI (-) group.
  • #61 Cited
    https://www.koreamed.org/SearchBasic.php?RID=2284011&DT=1
    Endoscopic bile reflux identified in 9.7% of all cases with gastrointestinal symptoms. […] Endoscopic bile reflux was common findings with young adults (30’s) at outpatients clinic. […] GB dysfunction were identified as significant risk factors for BRI (+) group.
  • #62 The Changing Epidemiology of Gastroesophageal Reflux Disease: Are Patients Getting Younger?
    https://www.jnmjournal.org/journal/view.html?doi=10.5056/jnm18140
    Our study showed that the proportion of patients with GERD has increased in all age groups, with the exception of those who were aged 70 years in both the universal and Healthcare system datasets. […] In our study, however, the greatest rise in the proportion of patients with GERD diagnosis was seen in young adults aged 30-39 years in both datasets during the last decade. […] An important finding of our study was the general characteristic of GERD patients who were primarily obese or severely obese, older women, and Caucasian. […] Our study suggests that physicians should be more aware that the proportion of young adults with GERD has been increasing continuously.
  • #63 Bile Reflux Gastritis: Insights into Pathogenesis, Relevant Factors, Carcinomatous Risk, Diagnosis, and Management
    https://pmc.ncbi.nlm.nih.gov/articles/PMC9484982/
    Although there is no golden standard for diagnosis of BRG, four vital techniques including hepatobiliary scintigraphy, gastroscopy with aspiration of gastric juice, fiberoptic bilirubin monitoring, and esophageal impedance-pH testing are commonly recognized. […] To date, there is still no official and unified therapeutic regimen for patients with BRG.
  • #64 Bile Reflux Gastritis: Insights into Pathogenesis, Relevant Factors, Carcinomatous Risk, Diagnosis, and Management
    https://pmc.ncbi.nlm.nih.gov/articles/PMC9484982/
    Although there is no golden standard for diagnosis of BRG, four vital techniques including hepatobiliary scintigraphy, gastroscopy with aspiration of gastric juice, fiberoptic bilirubin monitoring, and esophageal impedance-pH testing are commonly recognized. […] To date, there is still no official and unified therapeutic regimen for patients with BRG.
  • #65 Bile reflux after bariatric surgery | Cirugía Española (English Edition)
    https://www.elsevier.es/es-revista-cirugia-espanola-english-edition–436-articulo-bile-reflux-after-bariatric-surgery-S2173507723002235
    Recent trials that have attempted to directly treat bile as a component of gastro-oesophageal reflux disease (GORD) have demonstrated an improvement in symptoms and lesions in these patients. […] A new therapy, called IW-3718 (Colesevelam), binds and neutralises bile in the stomach, decreasing the volume of reflux and improving endoscopic imaging in 87% of cases, while also increasing muscle tissue relaxation. […] Despite the known histopathological links between oesophageal mucosal exposure to bile and carcinogenesis, only two cases of gastric pouch/distal oesophageal malignancy have been described in 20 years since the advent of OAGB. […] These results suggest that prospective trials of OAGB should include endoscopy preoperatively and at 5-year intervals to provide data on the true effects of bile exposure in the gastric reservoir and oesophagus. […] The HIDA scan is a sensitive measure of remnant pathology and is a readily available non-invasive test.
  • #66 Bile reflux after bariatric surgery | Cirugía Española (English Edition)
    https://www.elsevier.es/es-revista-cirugia-espanola-english-edition–436-articulo-bile-reflux-after-bariatric-surgery-S2173507723002235
    The growing epidemic of obesity and the increase in weight loss surgery has led to a resurgence of interest in biliary reflux because anatomical alterations may be refluxogenic. […] HIDA scan is the least invasive scan with good patient tolerability, sensitivity and reproducibility for the diagnosis of biliary reflux. […] Patients with more advanced oesophageal lesions have a higher degree of duodenal reflux. It has been shown in animal models and in vitro that there is more Barrett’s and dysplasia with duodenal reflux. […] Prospective trials on OAGB should include endoscopy preoperatively and at 5-year intervals, to have data on the real effects of bile exposure on the gastric reservoir and oesophagus. […] In the latest systematic review analysing the prevalence, symptoms, lesions and treatment of DGOR, several studies both in vitro and in vivo have implicated duodenal contents in the pathogenesis of oesophagogastric lesions.
  • #67 Bile reflux after bariatric surgery | Cirugía Española (English Edition)
    https://www.elsevier.es/es-revista-cirugia-espanola-english-edition–436-articulo-bile-reflux-after-bariatric-surgery-S2173507723002235
    Recent trials that have attempted to directly treat bile as a component of gastro-oesophageal reflux disease (GORD) have demonstrated an improvement in symptoms and lesions in these patients. […] A new therapy, called IW-3718 (Colesevelam), binds and neutralises bile in the stomach, decreasing the volume of reflux and improving endoscopic imaging in 87% of cases, while also increasing muscle tissue relaxation. […] Despite the known histopathological links between oesophageal mucosal exposure to bile and carcinogenesis, only two cases of gastric pouch/distal oesophageal malignancy have been described in 20 years since the advent of OAGB. […] These results suggest that prospective trials of OAGB should include endoscopy preoperatively and at 5-year intervals to provide data on the true effects of bile exposure in the gastric reservoir and oesophagus. […] The HIDA scan is a sensitive measure of remnant pathology and is a readily available non-invasive test.
  • #68
    https://journals.lww.com/jcat/fulltext/2017/09000/correlation_between_bile_reflux_gastritis_and.5.aspx
    This study aimed to evaluate the relationship between biliary excreted contrast media in the stomach and the presence of bile reflux gastritis. […] Biliary excreted contrast media in the stomach on 60-minute delayed gadoxetic MRC has a correlation with the presence of bile reflux gastritis on endoscopic examination. […] Bile reflux gastritis was significantly more common in patients with contrast media in the stomach on gadoxetic MRC (13/39 [33.3%]) than in those without contrast media (0/72 [0%]; P 0.001). […] The result of the linear-by-linear association revealed that patients with high-grade extension of contrast media in the stomach had significantly frequent bile reflux gastritis than did those with low-grade extension. […] Our study shows the applicability of MRI using hepatocyte-specific contrast media in detecting bile reflux.
  • #69
    https://journals.lww.com/jcat/fulltext/2017/09000/correlation_between_bile_reflux_gastritis_and.5.aspx
    This study aimed to evaluate the relationship between biliary excreted contrast media in the stomach and the presence of bile reflux gastritis. […] Biliary excreted contrast media in the stomach on 60-minute delayed gadoxetic MRC has a correlation with the presence of bile reflux gastritis on endoscopic examination. […] Bile reflux gastritis was significantly more common in patients with contrast media in the stomach on gadoxetic MRC (13/39 [33.3%]) than in those without contrast media (0/72 [0%]; P 0.001). […] The result of the linear-by-linear association revealed that patients with high-grade extension of contrast media in the stomach had significantly frequent bile reflux gastritis than did those with low-grade extension. […] Our study shows the applicability of MRI using hepatocyte-specific contrast media in detecting bile reflux.
  • #70
    https://journals.lww.com/jcat/fulltext/2017/09000/correlation_between_bile_reflux_gastritis_and.5.aspx
    Therefore, we suggest that the sensitivity of gadoxetic acidenhanced MRI is superior to that of gastroscopy in the diagnosis of bile reflux gastritis. […] In conclusion, biliary excreted contrast media in the stomach suggests duodenogastric bile reflux, and one third of the patients who showed contrast media in the stomach had bile reflux gastritis. The benefit of gadoxetic MRC is that it shows very high specificity to predict the presence of bile reflux gastritis. Moreover, the amount of reflux contrast media was significantly correlated with the presence of bile reflux gastritis.
  • #71
    https://link.springer.com/article/10.1023/A:1024130419914
    To avoid food impaction artifacts during ambulatory bile reflux monitoring (Bilitec), some groups have allowed only a liquid diet, while others omitted the meal and postprandial periods from the analysis. […] Thus, ambulatory Bilitec monitoring requires the use of liquid meals, as the use of solid meals is associated with too many meal artifacts and a poorer correlation with acid reflux and severity of endoscopic lesions.
  • #72 Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis | Scientific Reports
    https://www.nature.com/articles/s41598-020-62795-1
    Subjects with a moderate/high intake of carbonated drinks had a higher pooled prevalence of GORD than those with low/none intake (18.60% vs 14.54%, respectively). […] Pooling prevalence of GORD according to intake of coffee/tea revealed a higher GORD prevalence in subjects with a moderate/high intake of coffee/tea (21.02%) than those with a low/none intake (16.92%). […] This comprehensive systematic review has demonstrated the significant global burden of GORD with approximately 1.03 billion individuals suffering from the condition globally. […] It has also confirmed substantial variations in the pooled prevalence of GORD between regions and countries.
  • #73 The Changing Epidemiology of Gastroesophageal Reflux Disease: Are Patients Getting Younger?
    https://www.jnmjournal.org/journal/view.html?doi=10.5056/jnm18140
    Gastroesophageal reflux disease (GERD) is a common disease globally with increasing prevalence and consequently greater burden on the Healthcare system. […] Over the last decade, there has been a significant increase in the proportion of younger patients with GERD, especially those within the age range of 30-39 years. […] The increase in GERD prevalence may be due to multiple factors such as older age, male sex, race, intake of analgesics, consumption of certain types of food and drinks, decrease in the prevalence of Helicobacter pylori infection, smoking, family history of GERD, high body mass index (BMI), and limited physical activity. […] As risk factors for GERD increasingly affect the general population, concerns have been raised that more young individuals will develop GERD and its potential consequences.
  • #74 Reflux – Acid or Bile? Know the difference | Gastrointestinal Associates
    https://gihealthcare.com/reflux-acid-or-bile-know-the-difference/
    Bile reflux may occur in conjunction with GERD or may be misdiagnosed as GERD because the symptoms of the two conditions are very similar. […] Like GERD, identifying and treating bile reflux is important. When left untreated it can result in serious, sometimes life-threatening problems, such as esophageal ulcers that bleed and Barretts esophagus, a condition in which the cells in the lining of the esophagus transform into tissue similar to the type that lines the stomach. […] Bile reflux is common in individuals who have had surgery to remove their gallbladder or those who have undergone gastric surgery, including a total or partial removal of the stomach (gastrectomy) or gastric bypass surgery for weight loss. It also is common in patients with peptic ulcers. […] Because the symptoms of acid reflux and bile reflux are so similar, it is impossible to make a diagnosis of bile reflux based on symptoms alone.
  • #75 Gastroesophageal reflux disease – Wikipedia
    https://en.wikipedia.org/wiki/Gastroesophageal_reflux_disease
    In Western populations, GERD affects approximately 10% to 20% of the population and 0.4% newly develop the condition. For instance, an estimated 3.4 million to 6.8 million Canadians have GERD. The prevalence rate of GERD in developed nations is also tightly linked with age, with adults aged 60 to 70 being the most commonly affected. In the United States 20% of people have symptoms in a given week and 7% every day. […] No data supports sex predominance with regard to GERD.
  • #76 Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review | Gut
    https://gut.bmj.com/content/63/6/871
    Objective To update the findings of the 2005 systematic review of population-based studies assessing the epidemiology of gastro-oesophageal reflux disease (GERD). […] Results 16 studies of GERD epidemiology published since the original review were found to be suitable for inclusion (15 reporting prevalence and one reporting incidence), and were added to the 13 prevalence and two incidence studies found previously. The range of GERD prevalence estimates was 18.1%27.8% in North America, 8.8%25.9% in Europe, 2.5%7.8% in East Asia, 8.7%33.1% in the Middle East, 11.6% in Australia and 23.0% in South America. Incidence per 1000 person-years was approximately 5 in the overall UK and US populations, and 0.84 in paediatric patients aged 117years in the UK. Evidence suggests an increase in GERD prevalence since 1995 (p0.0001), particularly in North America and East Asia. […] Conclusions GERD is prevalent worldwide, and disease burden may be increasing. Prevalence estimates show considerable geographic variation, but only East Asia shows estimates consistently lower than 10%.
  • #77 Epidemiology of gastroesophageal reflux disease in Iran: a systematic review and meta-analysis | BMC Gastroenterology | Full Text
    https://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-020-01417-6
    A systematic review of longitudinal studies suggests that the incidence of GERD has increased in recent decades. If this trend continues, it may rapidly increase the serious complications of GERD, affect the patients quality of life, and increase the cost of health care systems. […] Increasing the GERD awareness to improve Iranian peoples health may be necessary. There is much information in Western cultures that can be generalized to an Iranian person but cannot match completely. Therefore, understanding the epidemiological effects of GERD in Iranian society can help healthcare professionals and policymakers take the next steps in creating the list of priorities for disease management.
  • #78 Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis | Scientific Reports
    https://www.nature.com/articles/s41598-020-62795-1
    The aim of the current review was to search the literature systematically using PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2009 guidelines and estimate the global prevalence of GORD, the prevalence of GORD according to geographical location and to identify risk factors associated with an increased risk of the condition. […] The pooled prevalence of GORD in females (17.17%) was moderately higher than in males (15.69%). […] The pooled prevalence of GORD according to age groups displayed an increase with increasing age between the age groups of 18-34 years (8.70%) and 35-59 years (14.53%). […] The pooled prevalence of GORD according to alcohol intake showed a similar GORD prevalence in those who do not drink alcohol or have a low intake of alcohol (15.95%) compared with those who have a moderate to high intake of alcohol (15.56%).
  • #79 Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis | Scientific Reports
    https://www.nature.com/articles/s41598-020-62795-1
    The aim of the current review was to search the literature systematically using PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2009 guidelines and estimate the global prevalence of GORD, the prevalence of GORD according to geographical location and to identify risk factors associated with an increased risk of the condition. […] The pooled prevalence of GORD in females (17.17%) was moderately higher than in males (15.69%). […] The pooled prevalence of GORD according to age groups displayed an increase with increasing age between the age groups of 18-34 years (8.70%) and 35-59 years (14.53%). […] The pooled prevalence of GORD according to alcohol intake showed a similar GORD prevalence in those who do not drink alcohol or have a low intake of alcohol (15.95%) compared with those who have a moderate to high intake of alcohol (15.56%).
  • #80 Reflux Esophagitis Pathology: Definition, Epidemiology, Etiology
    https://emedicine.medscape.com/article/1610393-overview
    A Swedish population-based, cross-sectional study compared the prevalence of gastroesophageal reflux symptoms among English and Swedish populations and reported a higher prevalence of reflux symptoms occurring at least twice weekly in English populations compared with Swedish populations. […] With regard to sex-related differences, some studies report no sex predilection. Other studies indicate that males are more likely to develop severe forms of esophagitis and complications such as Barrett esophagus and esophageal adenocarcinoma. Conversely, females are more frequently affected by nonerosive reflux disease (NERD) and symptomatic GERD. The prevalence of reflux esophagitis increases with age, particularly in females after their 50s. […] As noted in adults, there is an increasing trend of GERD in the pediatric population too. Nelson et al reported an increased incidence of GERD that ranged from 12% to 50% in children aged 0-18 years between 2000 and 2005.
  • #81 Gastroesophageal Reflux Disease: Practice Essentials, Background, Anatomy
    https://emedicine.medscape.com/article/176595-overview
    Western dietary habits have made GERD a common disease. The prevalence of GERD in Western populations is estimated to be 10-20%, whereas it is about 2.5-17.0% in Asian populations. […] Richter and associates reported that 25%-40% of Americans experience symptomatic GERD at some point. Approximately 7%-10% of Americans experience symptoms of GERD on a daily basis. Because many individuals control their symptoms with over-the-counter (OTC) medications and without consulting a medical professional, the actual number of individuals with GERD is probably higher. […] No sexual predilection exists: GERD is as common in men as in women. However, the male-to-female incidence ratio for esophagitis is 2:1-3:1. The male-to-female incidence ratio for Barrett esophagus is 10:1. White males are at a greater risk for Barrett esophagus and adenocarcinoma than other populations. […] GERD occurs in all age groups. The prevalence of GERD increases in people older than 40 years.
  • #82 Reflux Esophagitis Pathology: Definition, Epidemiology, Etiology
    https://emedicine.medscape.com/article/1610393-overview
    Interestingly, a study out of Taiwan by Chen et al showed seasonal variation in the incidence of GERD. Investigators evaluated a total of 76,636 ambulatory care visits for the treatment of GERD between 2001 and 2006 and reported that the incidence of GERD increased in autumn and winter for each sex, age group, as well as combined groups. They also reported that relative humidity showed a negative association with monthly GERD incidence in men and in the age group of those older than 64 years.
  • #83 Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis | Scientific Reports
    https://www.nature.com/articles/s41598-020-62795-1
    Stratified pooled prevalence of GORD by BMI showed an increase in GORD prevalence as BMI increased. […] The prevalence of GORD was highest in subjects with low education level (16.78%), followed by those with medium education level (11.52%), and the lowest GORD prevalence was seen in those with a high education level (8.98%). […] When the pooled prevalence of GORD was stratified according to marriage status, the highest prevalence of GORD was found in divorced/separated/widowed individuals (22.95%) followed by married individuals (15.98%), and the lowest GORD prevalence was seen in single individuals (12.85%). […] The pooled prevalence of GORD according to NSAIDs/aspirin use showed a significantly greater prevalence of GORD in subjects using NSAIDs/aspirin (24.47%) compared with those who do not (17.34%).
  • #84 Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis | Scientific Reports
    https://www.nature.com/articles/s41598-020-62795-1
    Stratified pooled prevalence of GORD by BMI showed an increase in GORD prevalence as BMI increased. […] The prevalence of GORD was highest in subjects with low education level (16.78%), followed by those with medium education level (11.52%), and the lowest GORD prevalence was seen in those with a high education level (8.98%). […] When the pooled prevalence of GORD was stratified according to marriage status, the highest prevalence of GORD was found in divorced/separated/widowed individuals (22.95%) followed by married individuals (15.98%), and the lowest GORD prevalence was seen in single individuals (12.85%). […] The pooled prevalence of GORD according to NSAIDs/aspirin use showed a significantly greater prevalence of GORD in subjects using NSAIDs/aspirin (24.47%) compared with those who do not (17.34%).
  • #85 Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis | Scientific Reports
    https://www.nature.com/articles/s41598-020-62795-1
    Stratified pooled prevalence of GORD by BMI showed an increase in GORD prevalence as BMI increased. […] The prevalence of GORD was highest in subjects with low education level (16.78%), followed by those with medium education level (11.52%), and the lowest GORD prevalence was seen in those with a high education level (8.98%). […] When the pooled prevalence of GORD was stratified according to marriage status, the highest prevalence of GORD was found in divorced/separated/widowed individuals (22.95%) followed by married individuals (15.98%), and the lowest GORD prevalence was seen in single individuals (12.85%). […] The pooled prevalence of GORD according to NSAIDs/aspirin use showed a significantly greater prevalence of GORD in subjects using NSAIDs/aspirin (24.47%) compared with those who do not (17.34%).
  • #86 Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis | Scientific Reports
    https://www.nature.com/articles/s41598-020-62795-1
    Stratified pooled prevalence of GORD by BMI showed an increase in GORD prevalence as BMI increased. […] The prevalence of GORD was highest in subjects with low education level (16.78%), followed by those with medium education level (11.52%), and the lowest GORD prevalence was seen in those with a high education level (8.98%). […] When the pooled prevalence of GORD was stratified according to marriage status, the highest prevalence of GORD was found in divorced/separated/widowed individuals (22.95%) followed by married individuals (15.98%), and the lowest GORD prevalence was seen in single individuals (12.85%). […] The pooled prevalence of GORD according to NSAIDs/aspirin use showed a significantly greater prevalence of GORD in subjects using NSAIDs/aspirin (24.47%) compared with those who do not (17.34%).
  • #87 Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis | Scientific Reports
    https://www.nature.com/articles/s41598-020-62795-1
    The area of domicile also had a significant effect on the prevalence of GORD. The pooled prevalence of GORD in subjects living in an urban area was the highest (13.43%) followed by subjects living in a rural area (11.70%). […] The pooled prevalence of GORD according to smoking habits showed that subjects who currently smoke had a higher prevalence of GORD (18.40%) compared with ex-smokers (16.83%) and non-smokers (15.55%). […] Subjects with a low income had a significantly higher prevalence of GORD (11.69%) than those with a medium income (8.42%) and those with a high income (7.68%). […] The effect of dietary intake of certain food and drinks (spicy food, sweet food, meat/fish, carbonated drinks, fatty food, fried food, and coffee/tea) on the pooled prevalence of GORD was also investigated.
  • #88 Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis | Scientific Reports
    https://www.nature.com/articles/s41598-020-62795-1
    The area of domicile also had a significant effect on the prevalence of GORD. The pooled prevalence of GORD in subjects living in an urban area was the highest (13.43%) followed by subjects living in a rural area (11.70%). […] The pooled prevalence of GORD according to smoking habits showed that subjects who currently smoke had a higher prevalence of GORD (18.40%) compared with ex-smokers (16.83%) and non-smokers (15.55%). […] Subjects with a low income had a significantly higher prevalence of GORD (11.69%) than those with a medium income (8.42%) and those with a high income (7.68%). […] The effect of dietary intake of certain food and drinks (spicy food, sweet food, meat/fish, carbonated drinks, fatty food, fried food, and coffee/tea) on the pooled prevalence of GORD was also investigated.
  • #89 Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis | Scientific Reports
    https://www.nature.com/articles/s41598-020-62795-1
    The aim of the current review was to search the literature systematically using PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2009 guidelines and estimate the global prevalence of GORD, the prevalence of GORD according to geographical location and to identify risk factors associated with an increased risk of the condition. […] The pooled prevalence of GORD in females (17.17%) was moderately higher than in males (15.69%). […] The pooled prevalence of GORD according to age groups displayed an increase with increasing age between the age groups of 18-34 years (8.70%) and 35-59 years (14.53%). […] The pooled prevalence of GORD according to alcohol intake showed a similar GORD prevalence in those who do not drink alcohol or have a low intake of alcohol (15.95%) compared with those who have a moderate to high intake of alcohol (15.56%).
  • #90 Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis | Scientific Reports
    https://www.nature.com/articles/s41598-020-62795-1
    Subjects with a moderate/high intake of carbonated drinks had a higher pooled prevalence of GORD than those with low/none intake (18.60% vs 14.54%, respectively). […] Pooling prevalence of GORD according to intake of coffee/tea revealed a higher GORD prevalence in subjects with a moderate/high intake of coffee/tea (21.02%) than those with a low/none intake (16.92%). […] This comprehensive systematic review has demonstrated the significant global burden of GORD with approximately 1.03 billion individuals suffering from the condition globally. […] It has also confirmed substantial variations in the pooled prevalence of GORD between regions and countries.
  • #91 Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis | Scientific Reports
    https://www.nature.com/articles/s41598-020-62795-1
    Subjects with a moderate/high intake of carbonated drinks had a higher pooled prevalence of GORD than those with low/none intake (18.60% vs 14.54%, respectively). […] Pooling prevalence of GORD according to intake of coffee/tea revealed a higher GORD prevalence in subjects with a moderate/high intake of coffee/tea (21.02%) than those with a low/none intake (16.92%). […] This comprehensive systematic review has demonstrated the significant global burden of GORD with approximately 1.03 billion individuals suffering from the condition globally. […] It has also confirmed substantial variations in the pooled prevalence of GORD between regions and countries.
  • #92 Bile reflux – Diagnosis & treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/bile-reflux/diagnosis-treatment/drc-20370121
    A description of your symptoms and knowledge of your medical history is usually enough for your doctor to diagnose a reflux problem. But distinguishing between acid reflux and bile reflux is difficult and requires further testing. […] There is little evidence assessing the effectiveness of bile reflux treatments, in part because of the difficulty of establishing bile reflux as the cause of symptoms. […] However, there’s little evidence about the surgery’s effectiveness for bile reflux. […] Make an appointment with your doctor if you have signs or symptoms common to bile reflux.
  • #93 Bile Reflux Gastritis: Insights into Pathogenesis, Relevant Factors, Carcinomatous Risk, Diagnosis, and Management
    https://pmc.ncbi.nlm.nih.gov/articles/PMC9484982/
    Although there is no golden standard for diagnosis of BRG, four vital techniques including hepatobiliary scintigraphy, gastroscopy with aspiration of gastric juice, fiberoptic bilirubin monitoring, and esophageal impedance-pH testing are commonly recognized. […] To date, there is still no official and unified therapeutic regimen for patients with BRG.
  • #94 Bile reflux – Diagnosis & treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/bile-reflux/diagnosis-treatment/drc-20370121
    A description of your symptoms and knowledge of your medical history is usually enough for your doctor to diagnose a reflux problem. But distinguishing between acid reflux and bile reflux is difficult and requires further testing. […] There is little evidence assessing the effectiveness of bile reflux treatments, in part because of the difficulty of establishing bile reflux as the cause of symptoms. […] However, there’s little evidence about the surgery’s effectiveness for bile reflux. […] Make an appointment with your doctor if you have signs or symptoms common to bile reflux.
  • #95 Gastro-esophageal reflux disease | Radiology Reference Article | Radiopaedia.org
    https://radiopaedia.org/articles/gastro-oesophageal-reflux-disease?lang=us
    It affects 10% to 20% of the adult population in the United States and Western countries. […] The difficulty in the radiographic diagnosis of gastro-esophageal reflux disease lies in the presence of spontaneous reflux on upper GI examination in 20% of normal individuals, while some patients with pathologic gastro-esophageal reflux disease may present with reflux only after provocative maneuvers such as Valsalva, leg raising, and coughing.
  • #96 Bile reflux – Diagnosis & treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/bile-reflux/diagnosis-treatment/drc-20370121
    A description of your symptoms and knowledge of your medical history is usually enough for your doctor to diagnose a reflux problem. But distinguishing between acid reflux and bile reflux is difficult and requires further testing. […] There is little evidence assessing the effectiveness of bile reflux treatments, in part because of the difficulty of establishing bile reflux as the cause of symptoms. […] However, there’s little evidence about the surgery’s effectiveness for bile reflux. […] Make an appointment with your doctor if you have signs or symptoms common to bile reflux.
  • #97 Reflux – Acid or Bile? Know the difference | Gastrointestinal Associates
    https://gihealthcare.com/reflux-acid-or-bile-know-the-difference/
    Bile reflux may occur in conjunction with GERD or may be misdiagnosed as GERD because the symptoms of the two conditions are very similar. […] Like GERD, identifying and treating bile reflux is important. When left untreated it can result in serious, sometimes life-threatening problems, such as esophageal ulcers that bleed and Barretts esophagus, a condition in which the cells in the lining of the esophagus transform into tissue similar to the type that lines the stomach. […] Bile reflux is common in individuals who have had surgery to remove their gallbladder or those who have undergone gastric surgery, including a total or partial removal of the stomach (gastrectomy) or gastric bypass surgery for weight loss. It also is common in patients with peptic ulcers. […] Because the symptoms of acid reflux and bile reflux are so similar, it is impossible to make a diagnosis of bile reflux based on symptoms alone.
  • #98 Once in a Bile — the Incidence of Bile Reflux Post-Bariatric Surgery. | EBSCOhost
    https://search.ebscohost.com/login.aspx?direct=true&profile=ehost&scope=site&authtype=crawler&jrnl=09608923&AN=156152475&h=2GJSF1PJyF73OrmExRmYCU%2BoFWw%2BjcMGvN%2BzHbLqzHqmgzAxks37ppS5Hp6Rsr8U54CuaRl3y9HmsOarH0GluA%3D%3D&crl=c
    Once in a Bile — the Incidence of Bile Reflux Post-Bariatric Surgery. […] Purpose: Excellent metabolic improvement following one anastomosis gastric bypass (OAGB) remains compromised by the risk of esophageal bile reflux and theoretical carcinogenic potential. […] No 'gold standard’ investigation exists for esophageal bile reflux, with diverse methods employed in the few studies evaluating it post-obesity surgery. […] As such, data on the incidence and severity of esophageal bile reflux is limited, with comparative studies lacking. […] Results: Gastric reflux of bile was identified by biliary scintigraphy in 14 OAGB (70%), one RYGB (5%) and four SG participants (31%), with a mean of 2.9% (SD 1.5) reflux (% of total radioactivity). […] One participant (OAGB) demonstrated esophageal bile reflux. […] Conclusion: Despite high incidence of gastric bile reflux post-OAGB, esophageal bile reflux is rare. […] With scarce literature of tumour development post-OAGB, frequent low-volume gastric bile reflux likely bears little clinical consequence; however, longer-term studies are needed.
  • #99 Bile reflux after bariatric surgery | Cirugía Española (English Edition)
    https://www.elsevier.es/es-revista-cirugia-espanola-english-edition–436-articulo-bile-reflux-after-bariatric-surgery-S2173507723002235
    The growing epidemic of obesity and the increase in weight loss surgery has led to a resurgence of interest in biliary reflux because anatomical alterations may be refluxogenic. […] HIDA scan is the least invasive scan with good patient tolerability, sensitivity and reproducibility for the diagnosis of biliary reflux. […] Patients with more advanced oesophageal lesions have a higher degree of duodenal reflux. It has been shown in animal models and in vitro that there is more Barrett’s and dysplasia with duodenal reflux. […] Prospective trials on OAGB should include endoscopy preoperatively and at 5-year intervals, to have data on the real effects of bile exposure on the gastric reservoir and oesophagus. […] In the latest systematic review analysing the prevalence, symptoms, lesions and treatment of DGOR, several studies both in vitro and in vivo have implicated duodenal contents in the pathogenesis of oesophagogastric lesions.
  • #100 Bile reflux after bariatric surgery | Cirugía Española (English Edition)
    https://www.elsevier.es/es-revista-cirugia-espanola-english-edition–436-articulo-bile-reflux-after-bariatric-surgery-S2173507723002235
    Recent trials that have attempted to directly treat bile as a component of gastro-oesophageal reflux disease (GORD) have demonstrated an improvement in symptoms and lesions in these patients. […] A new therapy, called IW-3718 (Colesevelam), binds and neutralises bile in the stomach, decreasing the volume of reflux and improving endoscopic imaging in 87% of cases, while also increasing muscle tissue relaxation. […] Despite the known histopathological links between oesophageal mucosal exposure to bile and carcinogenesis, only two cases of gastric pouch/distal oesophageal malignancy have been described in 20 years since the advent of OAGB. […] These results suggest that prospective trials of OAGB should include endoscopy preoperatively and at 5-year intervals to provide data on the true effects of bile exposure in the gastric reservoir and oesophagus. […] The HIDA scan is a sensitive measure of remnant pathology and is a readily available non-invasive test.
  • #101 Bile Reflux: Clinical Considerations – Gastroenterology Advisor
    https://www.gastroenterologyadvisor.com/features/tips-for-distinguishing-and-treating-biliary-reflux/
    Certain patients may develop biliary reflux based on having an acid-bile pocket in the proximal part of the stomach; this leads to a collection of bile and may predispose the patient to esophageal reflux. […] Identification of biliary reflux is important, as patients experiencing this can have more severe mucosal damage in the esophagus, including BE. […] A study conducted by Dixon et al found that patients with BE had more evidence of bile related gastritis compared with those reported as having only GERD or nonulcer dyspepsia. […] This study, along with others, raises the question as to whether there is a carcinogenic role of bile reflux. […] Therefore, patients with evidence of bile reflux should be considered for more aggressive therapy, in the hopes of potentially preventing negative sequelae such as BE. […] The authors concluded that duodeno-gastric bile reflux was present in at least 1/3 of patients with functional dyspepsia.
  • #102 Bile Reflux: Clinical Considerations – Gastroenterology Advisor
    https://www.gastroenterologyadvisor.com/features/tips-for-distinguishing-and-treating-biliary-reflux/
    Certain patients may develop biliary reflux based on having an acid-bile pocket in the proximal part of the stomach; this leads to a collection of bile and may predispose the patient to esophageal reflux. […] Identification of biliary reflux is important, as patients experiencing this can have more severe mucosal damage in the esophagus, including BE. […] A study conducted by Dixon et al found that patients with BE had more evidence of bile related gastritis compared with those reported as having only GERD or nonulcer dyspepsia. […] This study, along with others, raises the question as to whether there is a carcinogenic role of bile reflux. […] Therefore, patients with evidence of bile reflux should be considered for more aggressive therapy, in the hopes of potentially preventing negative sequelae such as BE. […] The authors concluded that duodeno-gastric bile reflux was present in at least 1/3 of patients with functional dyspepsia.
  • #103 Roles and action mechanisms of bile acid-induced gastric intestinal metaplasia: a review | Cell Death Discovery
    https://www.nature.com/articles/s41420-022-00962-1
    Long-term exposure to bile acids has been shown to increase the risk of transition from normal mucosa to IM, and eventually leads to the development of GC over many years. […] However, there are no clear studies on whether bile-reflux monitoring can be used to monitor and delay the development of gastric IM. […] Currently, there is a controversial debate whether or not gastric IM is reversible. […] It is generally believed that H. pylori eradication before the occurrence of gastric IM can help control gastritis, while once gastric IM is established, H. pylori eradication cannot reverse gastric IM but can help prevent or delay the progression of gastric IM. […] Therefore, more evidence is needed to determine whether H. pylori eradication can delay and reverse IM. […] In summary, the symptoms caused by bile reflux can be alleviated by drugs and surgery. However, there are no high-quality studies on whether the treatment of bile reflux can reverse IM.
  • #104 Roles and action mechanisms of bile acid-induced gastric intestinal metaplasia: a review | Cell Death Discovery
    https://www.nature.com/articles/s41420-022-00962-1
    Long-term exposure to bile acids has been shown to increase the risk of transition from normal mucosa to IM, and eventually leads to the development of GC over many years. […] However, there are no clear studies on whether bile-reflux monitoring can be used to monitor and delay the development of gastric IM. […] Currently, there is a controversial debate whether or not gastric IM is reversible. […] It is generally believed that H. pylori eradication before the occurrence of gastric IM can help control gastritis, while once gastric IM is established, H. pylori eradication cannot reverse gastric IM but can help prevent or delay the progression of gastric IM. […] Therefore, more evidence is needed to determine whether H. pylori eradication can delay and reverse IM. […] In summary, the symptoms caused by bile reflux can be alleviated by drugs and surgery. However, there are no high-quality studies on whether the treatment of bile reflux can reverse IM.
  • #105 Bile reflux after bariatric surgery | Cirugía Española (English Edition)
    https://www.elsevier.es/es-revista-cirugia-espanola-english-edition–436-articulo-bile-reflux-after-bariatric-surgery-S2173507723002235
    The growing epidemic of obesity and the increase in weight loss surgery has led to a resurgence of interest in biliary reflux because anatomical alterations may be refluxogenic. […] HIDA scan is the least invasive scan with good patient tolerability, sensitivity and reproducibility for the diagnosis of biliary reflux. […] Patients with more advanced oesophageal lesions have a higher degree of duodenal reflux. It has been shown in animal models and in vitro that there is more Barrett’s and dysplasia with duodenal reflux. […] Prospective trials on OAGB should include endoscopy preoperatively and at 5-year intervals, to have data on the real effects of bile exposure on the gastric reservoir and oesophagus. […] In the latest systematic review analysing the prevalence, symptoms, lesions and treatment of DGOR, several studies both in vitro and in vivo have implicated duodenal contents in the pathogenesis of oesophagogastric lesions.
  • #106 Bile Reflux following Single-Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy (SADI-S) and its Surgical Treatment : Bariatric Times
    https://bariatrictimes.com/bile-reflux-sadis-surgical-treatment/
    Bile reflux following the single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) procedure is rare. The reported incidence of bile reflux following the SADI-S procedure is 0.1 percent. […] Bile reflux can occur months to years after SADI-S. If it occurs, it can be fixed easily with surgical treatment.